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ABSTRACT 
 A greater understanding of the immune response after infection can form the 
necessary foundation of knowledge needed to enhance immunity through genetic selection.  
Whole genome microarrays allow for comprehensive analysis of the transcriptome.  The 
transcriptomic responses of spleen and peripheral blood leukocytes (PBL) each displayed 
differential expression in broiler chickens infected with avian pathogenic Escherichia coli 
(APEC), the causative agent for colibacillosis.  This differential expression was associated 
with treatment factors of infection status, pathology level and day post-infection.  Within the 
spleen, the largest number of significantly differentially expressed genes was between 
chickens with a severe pathology and those uninfected: 1,101 genes at 1 day post-infection 
and 1,723 genes at 5 days post-infection.  Significant differences in splenic expression 
between mild and severe pathology was only noted at 5 days post-infection, for 799 genes.  
Within PBL, the largest number of significantly differentially expressed genes was between 
mild and severe pathology on day 5, for 1,914 genes.  Significant differences in expression 
were also noted between severe pathology and uninfected chickens, for 1,097 genes at 1 day 
post-infection and for 506 genes at 5 days post-infection.  In both tissues, a severe 
pathological state resulted in more induction of gene expression response than repression.  
Several immune-related gene families, including the Toll-like receptors, cytokines and beta-
defensins, were differentially expressed in both tissues.  Combining results from the two 
tissues revealed potential pathway regulation between tissues over time.  MAPK pathway 
signaling in PBL at 1 day post-infection, could be causative for the downstream cytokine and 
p53 pathway signaling observed in the spleen at 5 days post-infection.  Vaccination against 
an APEC virulence factor generated no discernible difference in gene expression in either 
x 
tissue, with or without other factors of day, challenge, or pathology, although it was 
efficacious in reducing pathology, indicating further research is necessary to identify the 
impact of APEC vaccination on the transcriptome.  Combining this knowledge with 
genotypic markers could help to reveal the genomic locations responsible for conveying 
APEC resistance, allowing breeders to use this information to reduce the incidence of APEC 
infection in poultry.
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
 For poultry producers, avian pathogenic Escherichia coli (APEC) infection results in 
losses due to reduced productivity, discarded product, animal death and increased costs to 
prevent and treat disease, and to exterminate pathogens within their flocks (Barnes et al., 
2008).  Producers utilize a variety of mechanisms to combat disease within their flocks, such 
as antimicrobials, vaccination and the purchase of more robust birds from breeding 
companies, developed through genetic selection.  Global concern over antibiotic use in food 
animals has led to strict limitations being placed on their use and a greater need for research 
into alternative methods of disease control.  Vaccination against APEC can be problematic 
since, because of differences between disease causing serogroups, many vaccines do not 
protect well against a heterologous challenge.  Therefore, another method for disease control 
may be required: immune enhancement through genetic selection.   
Genetic improvement requires greater knowledge about how a host is able to 
effectively combat infection and the genetic architecture behind it, as testing disease 
resistance often removes animals from the breeding population.  The chicken is a pioneer in 
animal agriculture as a historically important model in genetics, developmental biology, and 
immunology, and the first agricultural animal to have its genome fully sequenced in 2004 
(Wallis et al., 2004).  The genome sequence has since been improved, with further builds and 
continuing efforts to map previously unknown regions.  This sequence information is 
invaluable in locating single nucleotide polymorphisms (SNP) for use in marker assisted 
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selection, quantitative trait loci (QTL) mapping and general annotation of genes and their 
function (as reviewed by Dodgson et al., 2011).   
Gene expression of host tissues to infection is commonly utilized to assess and 
enhance understanding of response to infection.  Microarray technology allows for 
simultaneous evaluation of thousands of genes.  Information from multiple tissues and 
thousands of genes facilitates the deduction of critical pathways, both within and between 
tissues, which are important in immune response.  The goal of the research summarized in 
this dissertation was to gain greater understanding of chicken host response to APEC.  
Transcriptomic response of spleen and peripheral blood leukocytes was assessed by using 
microarrays to identify host response mechanisms and elucidate the means through which a 
chicken is able to mount a successful defense against APEC. 
Organization of Dissertation 
 This dissertation is arranged in the alternative journal paper format that consists of 
five chapters containing three manuscripts for publication.  Chapter 1 is a general 
introduction and a review of relevant literature on the dissertation topic.  Chapter 2 is a 
manuscript published in BMC Genomics.  Chapter 3 is a manuscript prepared for 
Developmental and Comparative Immunology.  Chapter 4 is a manuscript prepared for Avian 
Diseases.  Chapter 5 is the discussion of the combined results of the dissertation, general 
conclusions and future directions of this research.  Figures and tables related to each 
manuscript appear at the end of each chapter.  Reference sections are at the end of each 
chapter.  References for manuscripts have been re-formatted from specific journal guidelines 
into a single format for consistency.  
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Literature Review 
Avian pathogenic Escherichia coli causes colibacillosis in chickens 
 Escherichia coli is a Gram-negative bacterium that is ubiquitously found in the 
environment and the gastrointestinal tract of animals.  The majority of E. coli encountered 
are harmless and are commonly part of healthy gut microflora, but others can result in 
disease.  In chickens, colibacillosis is characterized as an infection caused by an extra-
intestinal infection with avian pathogenic E. coli or APEC (Barnes et al., 2008).  It is a 
concern at all ages of poultry production, spreads through vertical and horizontal 
transmission, and results in a variety of manifestations of disease, with septicemia the most 
prevalent (as reviewed by Lutful Kabir, 2010).  Chickens are typically exposed to APEC 
orally into the gastrointestinal tract or through the respiratory tract (Matthijs et al., 2003), 
where it can quickly gain access to the bloodstream and colonize in other tissues (as 
reviewed by Dziva and Stevens, 2008).  This allows APEC access to the entire body, where it 
can colonize in a specific tissue, resulting in local infection, or remain in the bloodstream and 
colonize multiple regions for a systemic infection.  Respiratory exposure results in 
airsaccultis, percarditis and perihepatitis, with macro- and microscopic lesions identifiable 
within the respiratory system (Dwars et al., 2009, Peighambari et al., 2000).  Yolk sac 
infection of incubating and young broilers is a major cause of early mortality associated with 
APEC infection (Cortés et al., 2004).  In laying hens, APEC-induced septicemia, pericarditis 
and perihepatitis are still common, with ruptured follicles causing egg yolk peritonitis 
(Dhillon and Jack, 1996).  Poultry production is a multi-billion dollar industry annually in the 
U.S.  Colibacillosis results in large monetary losses through decreased production, death and 
carcass condemnation (Barnes et al., 2008), along with associated costs of disease treatment 
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and prevention.  Body weight and feed efficiency both decrease in broilers infected with 
APEC (Huff et al., 2006).  Several APEC isolates show resistance to antimicrobials, forcing 
the discovery of new control mechanisms (Gyles, 2008).  Research suggests transfer of 
antibiotic resistance or virulence plasmids between APEC and Salmonella is possible (Fricke 
et al., 2009), showing the need to control both so as to not enhance the virulence of the other.  
Bacterial infections are especially problematic for organic farms, where antimicrobials are 
strictly regulated.  E. coli was found to be the most common cause of mortality in an 
investigation of 15 organic Danish poultry flocks (Stokholm et al., 2010).  Although not as 
widely studied as other bacterial diseases, such as Salmonella, for the aforementioned 
reasons, APEC has become recognized as a major concern within the poultry industry.   
 A zoonotic bacterium is any bacterium which is able to be transmitted between 
animals and humans, resulting in disease.  Infection in food-production animals allows for 
potential foodborne transmission of zoonotic bacteria.  Fully cooked egg products and meat 
cooked to an internal temperature of 165°F, as recommended by the USDA, helps to protect 
consumers against bacterial exposure.  Poor kitchen practices can allow for recontamination 
of cooked products or contamination of uncooked ingredients (de Jong et al., 2008).  
Standard sanitation methods at processing plants are not enough to completely eliminate the 
risk of recontamination after cooking (Keeratipibul et al., 2009).  During slaughter, carcasses 
can be contaminated through contact with gut content or viscera and eggs through vertical 
transmission or fecal contamination of the shell (as reviewed by Lutful Kabir, 2010).  Among 
chicken carcasses at slaughter, over 99% contain some form of E. coli before evisceration 
and 38.7% still test positive after chilling (USDA FSIS, 2008).  Extra-intestinal pathogenic 
E. coli (ExPEC) can be isolated from retail meats, most commonly from poultry meat, that 
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show phylogenetic similarity to human ExPEC and resistance to multiple antimicrobials (Xia 
et al., 2011).  In addition to direct contact with poultry products, contaminated manure can 
spread bacteria into soil and water sources, providing routes of contamination for produce as 
well (as reviewed by Santamaría and Toranzos, 2003).  Therefore, prevention of infection 
and colonization by APEC in the chicken is key to reducing a potential food borne risk for 
humans.  APEC is a concern for human health as it shows many similarities to human 
ExPEC and improper handling of poultry products provides a route of exposure.  APEC 
genomic sequence displays strong sequence similarities to currently available human ExPEC 
sequences (Johnson et al., 2007).  Transcriptional similarities exist between APEC and 
ExPEC, with little evidence of host specificity discovered (Bauchart et al., 2010).  Many 
virulence genes are common to both APEC and uropathogenic E. coli isolates in type and 
rate of occurrence (Zhao et al., 2009).  Evidence of zoonotic potential for APEC has been 
established through its ability to cause disease in a rat model for human meningitis 
(Tivendale et al., 2010).  APEC has been shown to invade and survive in human cells 
(Chanteloup et al., 2011).  Transcriptional and virulence factor similarities between APEC 
and human ExPECs suggest the potential of APEC to act as a zoonotic source of human 
ExPEC or as a supply for ExPEC virulence genes. 
 The vast majority of chicken bacterial infection research to date has focused on 
Salmonella.  APEC, however, is gaining ground as it is now acknowledged as an important 
poultry and human health issue.  APEC is considered both a primary and secondary 
pathogen, with greater ability to cause disease in chickens already infected with other 
pathogens (as reviewed by Lutful Kabir, 2010).  Although APEC on its own is able to cause 
disease, prior infection with infectious bronchitis virus (IBV) can further impact host 
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response, reducing ability to combat new infection with APEC (Matthijs et al., 2009; 
Peighambari et al., 2000).  Bacteria, like APEC, are difficult to defend against because of the 
variety of strains and acquired resistances.  Such virulent bacteria can acquire the same 
resistance to host defenses as commensal bacteria, because plasmid transfer from bacteria 
located in the gut to those located in the respiratory tract has been documented (Dheilly et al., 
2011).  APEC O1:K1:H7 is sequenced, showing virulence genes associated with a common 
disease causing serotype (Johnson et al., 2007).  Knowledge of these virulence genes is 
important to understand how APEC is able to avoid conventional host immune responses, 
and what can be done to better prepare the host to resist infection.  Sequence data have 
allowed for successful identification of genes necessary for APEC O1 survival and growth in 
chicken serum (Li, G. et al., 2011), providing potential mechanisms to target to inhibit 
invasion. 
 APEC typically enters the host through ingestion or inhalation, after which it is able 
to translocate across mucosal layers and invade the bloodstream (as reviewed by Dziva and 
Stevens, 2008).  The internal environment of the chicken is typically a hazardous 
environment for foreign microorganisms.  APEC utilizes a variety of genes that allow it to 
adapt to stressful environments (Li, G. et al., 2011).  APEC virulence factors can also be 
located on plasmids which can transfer to other bacteria including non-pathogenic strains 
(Mellata et al., 2010).  APEC O1 is host to a variety of virulence factors that aid in survival, 
adhesion and invasion into host cells (Johnson et al., 2007).  APEC is able to resist 
complement (Nolan et al., 2002) and phagocytosis by macrophages (Bastiani et al., 2005).  
APEC requires the correct balance of iron to function.  Genes involved in iron acquisition 
and regulation are important to APEC survival and virulence (Li, G. et al., 2011).  Adhesion 
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genes, such as fimC, are more common among APEC than non-pathogenic E. coli (McPeake 
et al., 2005).  Although Shiga toxin genes have been discovered among APEC, they are not 
expected to be primary contributors to virulence (Parreira and Gyles, 2002).  Instead, other 
types of toxins, such as colicin (Dias da Silveira et al., 2002), and induction of apoptosis 
(Bastiani et al., 2005) contribute to virulence. 
Chickens have been utilized to better understand the human immune system.  The B-
cell is named after its discovery in the chicken’s bursa of Fabricius.  The similarities between 
APEC and human ExPEC, along with zoonotic potential, make the chicken an excellent 
candidate as a model organism for the study of human ExPEC.  The chicken has been a 
successful model organism for the study of Staphylococcus aureus induced arthritis (Zhou et 
al., 2007), vitiligo (Smyth et al., 1981), and ovarian cancer (Seo et al., 2011).  Uropathogenic 
E. coli (UPEC) has also shown marked similarities to APEC and is able to cause disease in 
the chicken (Zhao et al., 2009).  Because of similarities in the infectious agent, colibacillosis 
in chickens may serve as a model for human infection with ExPEC. 
Chicken host immune response to APEC infection 
 Chickens utilize a variety of mechanisms to protect against and combat pathogenic 
infection.  The chicken lacks traditional lymph nodes and must therefore rely on other 
methods of antigen presentation, such as gut- and bronchus-associated lymphoid tissues and 
an organ unique to Aves, the bursa of Fabricius.  The bursa of Fabricius is the primary site of 
B-cell development and proliferation of successfully rearranged IgM positive B-cells after 
day 15 of embryogenesis (Narabara et al., 2009).  Removal of the bursa from young results in 
failure to produce antibodies, but it plays a reduced role later in life because it begins to 
involute as the bird matures (Taylor and McCorkle, 2009).  Bursal weight, often measured as 
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an indicator of immune system health, and relative size can increase with immunomodulator 
supplementation (Bakyaraj et al., 2011).  Because APEC is typically inhaled or ingested, it 
bypasses the skin as a protective element.  Instead, the first lines of defense are the mucosal 
layers of the gastrointestinal and respiratory tracts.  Both the gastrointestinal tract and 
respiratory epithelium utilize IgA, a mucosal antibody.  Along with invading pathogenic 
bacteria, commensal bacteria reside in the gastrointestinal tract.  Commensal bacteria are 
beneficial to the host by aiding in digestion and have immune roles.  They are able to 
competitively exclude the colonization of harmful bacteria and suppress gut inflammatory 
responses, to protect themselves and the host from excessive inflammation (as reviewed by 
Brisbin et al., 2008).  Gut-associated lymphoid tissues (GALT) within the gastrointestinal 
tract help to store lymphocytes and produce immunoglobulins (Befus et al., 1980).  
Commensal and probiotic bacteria can interact with GALT cells to increase natural 
antibodies (Haghighi et al., 2006).  The respiratory system is a primary site of APEC 
infection as the main route of entry.  The chicken respiratory system does not contain 
resident immune cells and therefore relies more heavily on recruited heterophils and 
macrophages (as reviewed by Dziva and Stevens, 2008).  Within the bronchus form nodules 
called, bronchus-associated lymphoid tissue (BALT), which are a site of lymphocyte 
aggregation and antigen presentation (Fagerland and Arp, 1993).  BALT also contains 
phagocytic cells, which can be a source of recruitment during respiratory infection 
(Fagerland and Arp, 1993). 
In chickens, the spleen is the largest discrete lymphoid organ and plays an important 
role in innate and adaptive response (Oláh and Vervelde, 2008).  The spleen has many 
functions, including storage and a place for lymphocytes to aggregate with antigen presenting 
9 
cells such as dendritic cells and macrophages (Glick, 2000).  Isotype switching from the 
primary IgM to secondary IgG occurs in the germinal centers of the spleen (Jeurissen, 1993).  
Gene expression in the spleen is commonly studied and functions as an indicator of immune 
response (Abasht et al., 2009, Li, X. et al., 2011).  APEC can localize and colonize the spleen 
of chickens, as such the spleen has successfully been used for re-isolation of APEC after 
infection (Caza et al., 2008; Dheilly et al., 2011; Mellata et al., 2010).  Stimulation of 
chickens with a cell surface component of APEC, lipopolysaccharide (LPS), causes an 
increase in relative size of the spleen (Shini et al., 2008).  The spleen’s importance as an 
immunological organ can also be attributed to its interaction with leukocytes. 
 White blood cells, or leukocytes, are immune cells that protect the host against 
disease.  There are a variety of leukocytes; lymphocytes such as B- and T- cells, granulocytes 
such as heterophils, basophils and eosinophils, along with macrophages, dendritic cells and 
natural killer cells.  Heterophils are the first cell type to rapidly localize to sites of infection, 
where they play an important role in bacterial killing (Kogut et al., 1995).   Heterophils kill 
bacteria through a variety of mechanisms, such as extracellular traps (Chuammitri et al., 
2009), degranulation and release of enzymes and peptides (Kogut et al., 2001), and oxidative 
burst (Farnell et al., 2003), although the lack of myeloperoxidase results in a weakened 
oxidative burst (Conlon et al., 1991).  Improvements in heterophil function increase overall 
resistance to bacterial infections (Swaggerty et al., 2003).  Heterophil abundance and 
function has been shown to be variable and greatly dependent on genetic background of the 
population (Kogut et al., 2006; Redmond et al., 2011; Swaggerty et al., 2006).  Macrophages 
are involved in both the innate and acquired immune response.  Few tissues host resident 
macrophages, so recruitment and activation is required to respond to most sites of infection 
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(Qureshi, 2003).  Recognition of pathogen by cell surface receptors, such as toll-like 
receptors (TLR), results in rapid gene expression changes involved in macrophage 
phagocytosis and bacterial killing (Bliss et al., 2005).  Macrophages can also function as an 
antigen presenting cell for lymphocytes (Bliss et al., 2005).  Intra-tracheal inoculation of 
APEC resulted in macrophages localizing to site of infection, with subsequent clearance of 
bacteria (Matthijs et al., 2009).  Lymphocytes are primarily divided into two groups; B-cells 
which function in humoral immunity and T-cells with roles in cell mediated immunity.  B-
cells originate from the yolk sac and bone marrow before migrating to the bursa of Fabricius 
for further development (Lebacq and Ritter, 1979; Oláh and Vervelde, 2008).  They are 
producers of immunoglobulins and antibodies, products responsible for broad and targeted 
protection.  T-cells are found in the thymus and spleen, and are producers of cytokines 
(Lowenthal et al., 1994).  The number of mature T-cells, as indicated by cell surface markers 
CD3, 4, and 8, become more abundant in the first 2 weeks after hatch, but are not yet fully 
functionally active, contributing to the weaker immune system early in life (Lowenthal et al., 
1994).  Maturation involves generation of a functional T-cell receptor by recombination of 
gene segments, which is able to recognize antigen without recognizing self (Viertlboeck and 
Göbel, 2008).  T-cell receptor type and cluster of differentiation molecules help to 
distinguish different groups of T-cells, with proposed functions similar to mammalian T-cell 
classes (Viertlboeck and Göbel, 2008).  The ratio of heterophils to lymphocytes is commonly 
used as an indicator of stress in poultry, with increased heterophils and decreased 
lymphocytes indicative of a stressed state (Gross and Siegel, 1983).  Natural killer cells are 
classified as a lymphocyte and have cytotoxic capabilities which they use to kill foreign or 
infected cells (Juul-Madsen et al., 2008).  Dendritic cells are antigen presenting cells, 
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transitioning from immature to mature once an antigen is ready to present.  Maturation of 
dendritic cells is associated with a decrease in CC chemokine receptor (CCR) 6 and an 
increase in CCR7 expression (Wu et al., 2011). 
Different peripheral blood cell types use the spleen as an area of interaction and a 
source of cell development and education (Oláh and Vervelde, 2008).  By the time of hatch, 
B- and T-lymphocytes, and macrophages are already dispersed in the red pulp of the spleen 
(Mast and Goddeeris, 1999.)  T-cells rapidly multiply within the spleen during the first week 
of life (Lowenthal et al., 1994.).  IgM positive B-cells begin to appear in the spleen after 1 
week of age (Narabara et al., 2009).  CCR7 expression is much higher in the spleen than in 
other immune organs (Annamalai and Selvaraj, 2011), where migrating T-cells can interact 
with presented antigens from dendritic cells.  Populations of leukocytes in the spleen differ 
between lines selected for high or low antibody response, with more CD4+ and B-cells in the 
high antibody line and more CD8+ cells in the low antibody line (Parmentier et al., 1995). 
Both the spleen and peripheral blood leukocytes respond to and help protect the host 
from APEC infection through their independent functions and interactions in whole organism 
signaling.  Macrophages exposed to APEC in culture increase their expression of cytokines 
and oxidative burst genes (Lavrič et al., 2008).  Cultured macrophages not only illustrate the 
importance of cytokines and chemokines, but show the importance of TLR pathways in 
APEC response (Keeler et al., 2007).  Although virulence factors can protect APEC, 
heterophils and macrophages are able to reduce APEC by phagocytosis (Mellata et al., 2003).  
Insufficient recruitment of heterophils and macrophages in response to APEC infection is 
associated with chickens that are susceptible to cellulitis (Olkowski et al., 2005).  LPS 
stimulation results in a rapid reduction of CCR7 expression in the spleen (Annamalai and 
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Selvaraj, 2011), suggestive of a migration of stored leukocytes from the spleen to sites of 
infection. 
Along with select tissue types, several select genes and gene families hold important 
roles in immune response.  The major histocompatibility complex (MHC) was amongst the 
first major genes discovered for its role in the immune system and recognition of self.  It is 
involved in the training of leukocytes to prevent self-identification and autoimmunity.  In 
chickens, the MHC was discovered due to its association with the B blood group (Schierman 
and Nordskog, 1961).  The B blood group was first described by Briles et al. (1950) and 
because of its association with the MHC, certain B group haplotypes are associated with 
resistance to disease (as reviewed by Davison, 2003; Hunt et al., 2010; Kim et al., 2008).  
Compared to mammals, the chicken MHC is quite small (Kaufman et al., 1999).  Due to its 
small size and complexing of disease resistance traits, it is not surprising that other genes 
outside of MHC have been identified for their importance in immune response.   
Another early recognized gene family of importance for immune function was that 
responsible for immunoglobulins.  Immunoglobulins, also known as antibodies when specific 
to an antigen, are produced by B-cells.  Immunoglobulins (Ig) are separated into three 
different isotypes: IgM, the first antibody type produced; IgG, which is also referred to as 
IgY and is the second type produced, and IgA (as reviewed by Ratcliffe, 2006).  There is no 
clear consensus as to the existence of mammalian IgE and IgD homologues in the chicken.  
Early reports of an IgD homologue have not been replicated or expanded upon (Chen et al., 
1982).  IgY is the predicted evolutionary precursor to mammalian IgG and IgE (Aveskogh 
and Hellman, 1998), and shows structural similarities to IgE, although conducting primarily 
IgG type function (Taylor et al., 2008).  Chickens do not have a large repertoire of light and 
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heavy chains for antibody construction compared to other species, so genetic variability for 
Ig molecules primarily comes from gene conversion and somatic hypermutation, rather than 
chain rearrangement (Ratcliffe, 2008).   
Toll-like receptors (TLR) are a type of pattern recognition receptor that detect 
molecular components common to many pathogens.  Each TLR recognizes a specific agonist 
that is unique to a particular pathogen.  In chickens, TLR4 and 5 recognize 
lipopolysaccharide (Dil and Qureshi, 2002; Leveque et al., 2003) and flagellin (Iqbal et al., 
2005; Keestra et al., 2008), respectively, which are both common to Gram-negative bacteria 
like APEC.  Other TLRs, such as TLR7, 15, and 21, are not typically associated with 
bacterial infection, but more often with antigens, imiquimod (Brownlie et al., 2009) and 
ssRNA (Philbin et al., 2005) for TLR7, and with CpG oligodeoxynucleotides for TLR15 
(Ciraci and Lamont, 2011) and TLR21 (Brownlie et al., 2009).  Despite this, there is 
evidence that these TLRs will also respond to Gram-negative bacteria like APEC (Ciraci and 
Lamont, 2011; de Zoete et al., 2010; Nerren et al., 2010).  Consistent with their role in 
immune response, TLR expression is greater among immune-related tissues such as spleen 
and peripheral blood leukocytes than in other tissues (Philbin et al., 2005).  TLRs help 
mediate oxidative burst response in heterophils (Farnell et al., 2003).  Several TLRs are 
differentially expressed in response to bacterial infection (Abasht et al., 2009).  Different 
breeding lines have shown differential TLR expression following Salmonella challenge 
(Abasht et al., 2009).  TLR signaling initiates down-stream responses, including changing 
expression of cytokine genes. 
 Cytokines are cell signaling molecules of the immune system involved in regulating 
pro- and anti-inflammatory responses and recruitment of leukocytes to sites of infection, 
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chemokines.  Pro-inflammatory cytokines, such as interleukin-1β and interleukin-6, aide in 
the destruction of pathogens, while anti-inflammatory cytokines, such as interleukin-10, help 
to protect the host against excessive inflammation.  With the completion of the genome 
sequence, greater knowledge has been gained about the location and structure of cytokines 
and chemokines (Kaiser et al., 2005).  Elevated levels of pro-inflammatory cytokines and 
chemokines were noted in heterophils from a Salmonella resistant chicken line compared to a 
susceptible line, while anti-inflammatory TGF-β4 was reduced (Swaggerty et al., 2006).  
Increases in pro-inflammatory cytokines have also been associated with LPS injection (De 
Boever et al., 2009).  Administration of recombinant interferon gamma has been shown to 
increase immune response to E. coli through increased phagocyte activity, increased 
interleukin 6 production and increased recruitment of MHC II cells (Janardhana et al., 2007).   
 Avian beta-defensins (AvBD), previously referred to as gallinacins, are a family of 
cationic antimicrobial peptides with broad-spectrum activity found in epithelial cells and 
leukocytes (Milona et al., 2007).  Fourteen different genes have been discovered in this 
family within a small region on chromosome 3 (Lynn et al. 2007; Xiao et al., 2004).  Avian 
beta-defensins act by binding to components of the bacterial membrane surface, resulting in 
depolarization, membrane disruption and death (Brogden, 2005; Sugiarto and Yu, 2007).  
Heterophil derived AvBD exhibit the ability to kill Escherichia coli (Evans et al., 1994).  
AvBD4,7, and 9 have proven ability to kill Salmonella (Milona et al., 2007).  Chicken 
populations resistant to bacterial infection from Salmonella exhibit higher basal levels of 
AvBD (Derache et al., 2009).  Allelic differences have been identified among AvBD genes, 
which are associated with differences in immune response and functionality.  SNPs within 
AvBD genes are associated with antibody response to Salmonella vaccination and with 
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bacterial load in the cecum and spleen of advanced intercross lines derived from commercial 
breeds (Hasenstein et al., 2006; Hasenstein and Lamont, 2007).  In song birds, specifically 
the great tit, alternate alleles of AvBD7 were associated with different levels of killing ability 
between Gram-positive and Gram-negative bacteria (Hellgren et al., 2010).  Targeted amino 
acid substitution within AvBD8 can increase its effectiveness against Escherichia coli (Higgs 
et al., 2007).  Like many immune genes, unchecked activity can have a deleterious effect.  
AvBD activity past levels necessary for bacterial killing can result in haemolysis up to 20% 
(Milona et al., 2007). 
Current practices to combat infection: What can we do against APEC? 
 The shift in production from small scale flocks to large, enclosed production systems 
influences how disease can be introduced and spread.  Good biosecurity practices are the first 
step to avoid exposure to pathogens.  Comparisons of biosecurity recommendations illustrate 
many common practices, such as wearing disposable boots or utilizing footbaths, clean 
clothing in facilities, disinfecting equipment, restricted animal access and utilizing all-in/all-
out systems (Moore et al., 2008).  Many inconsistencies in delivery of information exist 
however, which may reduce implementation and effectiveness of these practices (Moore et 
al., 2008).  Along with larger flocks, poultry production has become geographically more 
condensed (Graham et al., 2008).  Areas of high density production can increase risk through 
more frequent exchanges of personnel and equipment associated with individual facilities 
(Vieira et al., 2009).  Although following recommended biosecurity practices reduces the risk 
of disease spread, the potential for disease introduction through insects, rodents, 
contaminated feed or other sources merits use of other control mechanisms. 
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 Antimicrobial treatment is a common method to combat bacterial infection.  APEC is 
difficult to combat because many isolates display resistance against many of the commonly 
used antimicrobials (Zhao et al., 2005).  Commensal E. coli shows resistance to several 
antimicrobials as well (Krueger et al., 2011), making it a potential source of resistance genes 
for APEC.  Use of multiple antimicrobials, oxytetracycline, trimethoprim-sulfadimethoxin, 
and enrofloxacin, has been shown to control extent of pathology after challenge with several 
resistant APEC strains (Dheilly et al., 2011).  Oxytetracycline administered in drinking water 
alone has not been able to control the spread of APEC in layer houses, although chlorine was 
able to control water borne spread (Dhillon and Jack, 1996).  Therapeutic and sub-therapeutic 
levels of antibiotics have been fed to chickens for the purpose of maintaining good health and 
increasing production performance.  Concern about generating antimicrobial-resistant 
bacteria through the use of antibiotics as growth promoters, use in continuous sub-therapeutic 
doses, and increases in organic farming are leading to the ban of antimicrobial use at sub-
theraputic levels for enhancement of production.  Organic poultry farming operations have 
continued to rise in number since 1997 (USDA ERS, 2008).  Organic farming creates an 
increased demand for disease control options other than the administration of antibiotics.  
The European Union has already banned the use of antibiotics as growth promoters 
(Casewell et al., 2003).  Several antimicrobials have been banned by the FDA for poultry 
usage, such as flouroquinolones like enrofloxacin.  Studies evaluating current and past levels 
of antimicrobial resistance during drug use and following subsequent drug bans have shown 
mixed results.  Although some studies illustrate increases in the percentage of antimicrobial 
resistant strains following feed supplementation of antibiotics, it is difficult to differentiate a 
change in bacterial population structure from an increase in newly acquired antibiotic 
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resistances by bacteria (da Costa et al., 2008; Diarra et al., 2007; Thibodeau et al., 2008).  
Resistance rates for Campylobacter following the enrofloxacin ban appear to have decreased 
(Han et al., 2009). 
Administration of bacteriophage, viruses that kill bacteria, has been effective at 
reducing mortality in chickens (Huff et al., 2010; Lau et al., 2010).  Bacteriophage 
administration is limited due to antibody production against the phage after first exposure, 
decreasing effectiveness (Huff et al., 2010).  So while bacteriophage administration may 
make an effective one time post-infection treatment, it may have limitations as a preventative 
measure.  Dietary immunomodulators such as pre- and probiotics have also come into use to 
improve chicken health.  Prebiotics ascorbic acid and β-glucans fed in the diet of broilers 
induce changed expression of cytokines in the spleen (Redmond et al., 2010).  Probiotic 
supplementation of chicks can reduce incidence and colonization of pathogenic bacteria 
(Menconi et al., 2011) and change cytokine expression in the spleen (Brisbin et al., 2010). 
 Vaccination is a preventative technique by which an introduced antigen induces an 
adaptive immune response.  Vaccines developed and tested against a single serogroup of 
APEC have proven effective at increasing anti-lipopolysaccharide IgG and IgA levels, along 
with a decrease in circulating bacteria levels (Yaguchi et al., 2009).  The difficulty is finding 
a vaccine that is effective against a heterologous challenge.  Previous vaccines developed 
against APEC adhesion domain of FimH were not able to induce a protective response 
against APEC challenge (Vandemaele et al., 2005).  Other virulence proteins, such as iss, 
increased serum survival, are much more common among APEC isolated from diseased birds 
than E. coli from healthy birds (McPeake et al., 2005), and are suspected to be an outer 
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membrane protein (Barondess and Beckwith, 1995).  A vaccine developed against iss has 
shown protective capabilities against heterogonous challenge (Lynne et al., 2006).   
 Breeding populations to increase resistance to disease is an attractive alternative to 
antibiotics.  Commercial have focused on increasing production of commercial traits instead 
of immune response, so it may be necessary to utilize non-commercial populations to 
improve response.  Genetic selection impacts management decisions, because genetic 
background impacts the effectiveness of vaccines (Chang et al., 2010) and other 
immunomodulators (Redmond et al., 2010; Redmond et al., 2011).  Populations bred to 
utilize vaccination and dietary supplementation more effectively will be better protected from 
disease and reduce costs for producers.  Genetic selection requires intensive phenotyping and 
research, which are typically associated with high costs.  New technologies to measure 
phenotypes and genotypes will hopefully reduce costs, which, when combined with effective 
breeding strategies, will allow for breeding programs that can effectively utilize phenotypic 
training data over multiple generations.   
Principles and techniques behind genetic improvements 
 The basic principle behind evolution and genetic selection is change over time.  
Historically, breeders relied on phenotypic information that could be measured on the 
breeding stock.  This presents a difficulty in the instance of sex-limited traits or traits that 
would result in the sacrifice of breeding stock to measure, requiring extrapolation based on 
pedigree and family records.  The use of selection indices and BLUP estimation of breeding 
values allows for even better selection of breeding animals with improved genetic response, 
than selection based purely on phenotypic data (Morris and Pollott, 1997).  New technology 
allows breeders to measure and utilize pedigree and genetic information, such as genotypes 
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for genetic markers for quantitative trait loci associated with traits of interest and gene 
expression data.  Marker assisted selection allows for more rapid and economical selection 
by eliminating the need to wait for progeny data in sex limited traits or sacrifice of breeding 
stock for disease testing (as reviewed by Dekkers, 2004).  Genome-wide association studies 
use genetic markers, such as SNPs, across the entire genome to look for asssociations with a 
particular trait of interest.  Genome-wide association studies predict that large numbers of 
loci are responsible for complex traits, such as immune response, and can be captured 
through whole-genome scans with large SNP panels (Hayes and Goddard, 2010).  Provided 
enough phenotypic and genotypic data is available, predicted phenotypes based on genome-
wide marker data can be accurate for traits unable to be observed on breeding animals, like 
disease resistance (Lee et al., 2008).  Genomic selection, which fits the estimated effects for 
all markers, has proven to be a more beneficial selection method than standard BLUP for 
traits with low heritability (Piyasatian et al., 2007).  Genomic estimated breeding values, 
breeding values estimated from genomic associations to QTL, are expected to be even more 
effective than reliance on strictly on pedigree data (Wolc et al., 2011).  For any of these 
selection techniques to be applied, extensive phenotype data is required on genotyped 
individuals.   
 It is difficult to identify an animal with a superior immune response due to genetics.  
In vivo experimentation can be utilized to measure pathology and survival rate of the flock, 
but at the cost of potential breeding animals.  Mock-infection with a non-pathogenic antigen 
can yield information about immune response, but can be antigen specific and give limited 
information related to survival (De Boever et al., 2009).  In vitro stimulation of cell cultures, 
with bacteria or other agonists, allows for investigation of a particular cell type and utilize 
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techniques such as RNAi to investigate gene roles (Lavrič et al., 2008; Ciraci and Lamont, 
2011).  For traits to be practical in breeding, they need to be heritable and either associated 
with markers in order to use pedigree information or measurable on the breeding animal.  
Traditional immune traits measured through in vivo study have found associated genetic 
markers.  Resource populations exhibiting high and low antibody response to E. coli 
vaccination have been successfully utilized to discover microsatellite markers associated with 
antibody production (Yunis et al., 2002) and survival rate (Yonash et al., 2001).  Another 
trait that can be measured in in vitro or in vivo studies is gene expression.  Gene expression is 
influenced by infection and can be measured on multiple tissues to give insight into the 
regulation of genes and pathways during infection. 
 Multiple technologies have been developed to assay gene expression response.  
Microarray technology allows for the investigation of several thousands of genes at the same 
time.  Microarray platforms exist for multiple species, including chickens, some targeted to 
specific cell types (Bliss et al., 2005) or gene sets (Keeler et al., 2007; Smith et al., 2006), 
while others are more global.  The chicken currently has a global microarray available, with 
42,034 features, which is able to detect expression levels across a variety of tissues (Li et al., 
2008).  Transcriptomic response to bacterial infection has been assessed utilizing this 
microarray to better understand chicken, host, response to Campylobacter (Li et al., 2010; Li, 
X. et al., 2011), Salmonella (Chiang et al., 2008), and laryngotacheitis virus (Lee et al., 
2010).  Global gene expression platforms allow for the discovery of novel genes involved in 
immune response, as a non-specific assay, giving greater insight into pathways and signal 
cascades that change during infection.  
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 Quantitative PCR (QPCR) is another technology utilized to measure gene expression 
in a more targeted manner.  Quantitative PCR targeted expression is useful when specific 
genes or gene families are known to be involved in response and has been used successfully 
in the chicken (Abasht et al., 2009; Ciraci and Lamont, 2011; Redmond et al., 2009).  QPCR 
is regarded as technically more precise and repeatable than microarrays, and for this reason it 
is the standard to use in technical validation of microarray results (Larkin et al., 2005).   
 High-throughput sequencing machines have allowed for the recent development of 
RNA-sequencing (RNA-seq) technology.  Although a new technology, RNA-seq appears to 
be a very reliable method of measuring RNA expression which, unlike microarrays, also 
allows for detection of genes with low levels of expression, splice variants and novel 
transcripts (Marioni et al., 2008).  Most RNA-seq studies were not published on until 2008, 
but its recognition as a ground-breaking new tool for transcriptomic research has led to over 
300 published manuscripts in the Pub-Med database using this technology in the past 3 years.  
RNA-seq technology has been successfully utilized in humans to investigate transcriptomic 
response to disease (Twine et al., 2011).  As of August 2011, only one paper has utilized 
RNA-seq in chickens (Wolf and Bryk, 2011), illustrating its ability to be utilized within a 
chicken transcriptome and the need to utilize the technology more. 
Creating an enhanced immune response through genetic selection 
First efforts at breeding for enhanced immune response were through the MHC by 
selecting for B blood groups resistant to disease.  As MHC haplotype is a discreet trait, it is 
easily selected for and can be introgressed into commercial populations.  Various MHC 
haplotypes have been associated with resistance to Eimeria maxima (Kim et al., 2008), avian 
influenza (Hunt et al., 2010) and Marek’s disease (as reviewed by Davison, 2003).  The 
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disadvantage to single gene selection is that a given allele isn’t always beneficial for all traits.  
The B21/B21 haplotype, resistant to Marek’s disease virus, is associated with a higher 
incidence of E. coli derived cellulitis in broilers than the B13/B13 haplotype, but surprisingly 
no change in severity of pathology (Macklin et al., 2009).  This is contradictory to a study 
showing that the B21/B21 haplotype is associated with greater survival after APEC challenge 
in layers (Cavero et al., 2009).  This condradiction may be explained by differences in 
selection history and genetics of the two populations assessed, layers compared to broilers.  
While the MHC plays a large role, disease resistance is expected to be polygenic in nature, 
requiring investigation into what genes contribute to this resistance. 
Phenotype based selection has been utilized to improve polygenic immune traits.  
Mice populations have been successfully divergently selected for antibody response to sheep 
and pigeon red blood cells (Biozzi et al., 1970).  These “high” and “low” responder lines 
were found to divergently respond to multiple types of antigen.  Selection for a specific 
antigen resulted in an increase in antibody production against other antigens, allowing for 
broad spectum performance increases.  Selection for high antibody production appeared to 
decrease emphasis on cellular immunity, as the low line saw higher macrophage catabolic 
activity than the high responder line (Mouton et al., 1984).  Unfortunately for production 
species, breeding for enhanced commercial production traits has resulted in reduced pressure 
on immunity and commercial breeds have been shown to be weaker responders to infection 
than non-production breeds (Redmond et al., 2009).  However, even within commercial 
broiler chicken populations, resistant and susceptible genetic lines have been discovered 
against an APEC challenge for mortality and lesions (Ask et al., 2006).  Studies on APEC 
resistance have found no significant association between mortality and production traits 
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(Cavero et al., 2009).  Heritability estimates for resistance against a particular pathogen are 
typically low, 0.12 for mortality to Salmonella (Janss and Bolder, 2000) and 0.17 for 
resistance to APEC (Cavero et al., 2009).  Taking advantage of the new breeding techniques 
can help to improve heritability estimates and accuracy.  Resistance to disease is a very 
complex trait, resulting in hard to define characteristics and low heritability.  Focusing 
breeding efforts on a particular component of disease resistance can increase heritability.  
Heritability estimates for heterophil to lymphocyte ratio are high at 0.59, along with 
hertiability estimates for heterophil and leukocyte numbers individually (Campo and Davila, 
2002).  Increase in antibody response to E. coli vaccination has a high heritability of 0.44 
(Yonash et al., 1996).  Gene expression has been shown to be moderately heritable in human 
studies (Monks et al., 2004; Price et al., 2011), making selection on gene expression an 
option to explore for breeders. 
Gene expression profiles help to identify and quantify pathways regulated in response 
to infection.  Investigation into differentially expressed genes can allow investigators to 
decipher the optimal expression profile for pathogen elimination without causing self-
inflicted pathology.  Expression of immune related genes has been shown to be heritable in 
the chicken.  Parental chickens with high and low expression levels of immune related genes 
produced chicks with increased or decreased expression levels (Swaggerty et al., 2008), 
although heritability was not estimated.  Populations bred for resistance or susceptibility to 
Salmonella show different expression patterns both before and after infection, illustrating a 
role for expression profiles in disease resistance (Derache et al., 2009; Sadeyen et al., 2004).  
Cytokines from distinct genetic lines, meat type, egg type, and an Eqyptian breed that hasn’t 
undergone commercial selection, differ in their response to Salmonella in vitro (Redmond et 
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al., 2009).  Background genetics impacts gene expression, so extensive research of current 
production lines is necessary to determine the best method to increase immune response.  
SNP studies have identified QTLs and genes thought to be responsible for expression 
differences, allowing producers to use SNP genotype information of parental stock in their 
breeding programs (Le Bihan-Duval et al., 2011, Smith et al., 2011). 
 The tools necessary for developing a successful breeding program against APEC 
exist.  Genetic background has proven to be a factor in disease resistance.  Gene expression is 
a valuable assay to measure the ideal basal and response expression levels to infection.  Very 
little is known about in vivo chicken gene expression response to APEC infection.  Many 
disease studies choose to focus on cell culture responses; while valuable, they may leave 
gaps in our knowledge of whole organism responses.  Multiple tissue analysis taken from 
whole organisms for estimation of disease response should provide insight into systems 
biology.  This foundational research is necessary for discovery of new targets of interest for 
future studies and MAS programs.  Proper application of genetics research should increase 
resistance to disease while making an effort to maintain production levels. 
Experimental design and sample selection for this study 
 A large-scale animal experiment was carried out to generate the necessary samples 
for this study. The overall goal of the study was to increase the scientific understanding of 
host genomics of response to APEC.  In total, approximately 720 chickens were used with 
120 birds in each of 6 replicates conducted at different times.  Within each replicate, half of 
the birds were vaccinated or non-vaccinated at 2 weeks of age, that is, 60 birds into each 
partition.  Treatment groups that were challenged with APEC at 4 weeks of age had a larger 
proportion of chickens, 48 vaccinated birds were challenged and 48 non-vaccinated birds 
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were challenged.  Twelve birds were included in the non-challenged, vaccinated group, and 
12 birds in the non-challenged, non-vaccinated group.  Half of the birds from each treatment 
group were harvested for sample collection at each of two time points, 1 and 5 days post 
challenge.  The large number of birds in APEC-challenged groups allowed for identification 
of a large range of pathology phenotypes, which was used to further divide the non-
vaccinated, challenged treatment groups in to two phenogroups each: mild and severe 
pathology.  Therefore, the two vaccine treatments, two APEC-challenge statuses, two tissue-
harvest times, and the further division of the two non-vaccinated, challenged groups into two 
phenogroups each, resulted in a total of ten treatment groups for analysis. 
 Individuals, rather than pools, were used for the microarray analysis performed within 
this dissertation study, to allow for a clear connection to pathology phenotype and the ability 
to analyze multiple tissues from the same individual birds.  Four of the 6 replicates were 
utilized; two replicates were not used because they were subject to non-treatment factors.  
One individual was selected as a treatment group representative for each of the four 
replicates, resulting in a total of 40 samples assayed on the microarrays.  Selection of the 
samples from the non-vaccinated, challenged groups was based on pathology scores, 
identifying the most extreme mild and severe scores, scores closest to the minimum of 0 and 
the maximum of 7.  For the other treatment groups, birds were selected to be the best average 
representative of that treatment group.  A limiting factor for inclusion in the study was the 
availability and quantity of spleen and leukocyte tissues for RNA isolation.  Sufficient 
isolated quantity of tissue was necessary for good RNA yield and quality required for 
microarray analysis. 
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Abstract  
Background 
 Avian pathogenic Escherichia coli (APEC) is detrimental to poultry health and its 
zoonotic potential is a food safety concern.  Regulation of antimicrobials in food-production 
animals has put greater focus on enhancing host resistance to bacterial infections through 
genetics.  To better define effective mechanism of host resistance, global gene expression in 
the spleen of chickens, harvested at two times post-infection (PI) with APEC, was measured 
using microarray technology, in a design that will enable investigation of effects of 
vaccination, challenge, and pathology level. 
Results 
 There were 1,101 genes significantly differentially expressed between severely 
infected and non-infected groups on day 1 PI and 1,723 on day 5 PI.  Very little difference 
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was seen between mildly infected and non-infected groups on either time point.  Between 
birds exhibiting mild and severe pathology, there were 2 significantly differentially expressed 
genes on day 1 PI and 799 on day 5 PI.  Groups with greater pathology had more genes with 
increased expression than decreased expression levels.  Several predominate immune 
pathways, Toll-like receptor, Jak-STAT, and cytokine signaling, were represented between 
challenged and non-challenged groups.  Vaccination had, surprisingly, no detectible effect on 
gene expression, although it significantly protected the birds from observable gross lesions.  
Functional characterization of significantly expressed genes revealed unique gene ontology 
classifications during each time point, with many unique to a particular treatment or class 
contrast. 
Conclusions 
 More severe pathology caused by APEC infection was associated with a high level of 
gene expression differences and increase in gene expression levels.  Many of the significantly 
differentially expressed genes were unique to a particular treatment, pathology level or time 
point.  The present study not only investigates the transcriptomic regulations of APEC 
infection, but also the degree of pathology associated with that infection.  This study will 
allow for greater discovery into host mechanisms for disease resistance, providing targets for 
marker assisted selection and advanced drug development. 
Background  
 Maintaining proper food-animal health is important from an animal welfare, animal 
production and food safety standpoint.  Avian pathogenic Escherichia coli (APEC) are a 
group of extraintestinal E. coli that commonly infect poultry.  Infection can lead to 
colibacillosis, a disease that can be localized or systemic, with the more acute and serious 
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forms ending in septicemia and death (Barnes et al., 2008; as reviewed by Lutful Kabir, 
2010).  Colibacillosis is one of the most frequent diseases in poultry resulting in mortality 
losses at all stages of life and decreased production efficiency in older birds (Barnes et al., 
2008; Russell, 2003).  Mortality, decreased production and condemnation of contaminated 
product may result in significant economic losses to the poultry industry worldwide (Barnes 
et al., 2008; Bisaillon et al., 1988; as reviewed by Lutful Kabir, 2010; Sams, 2001). 
 APEC can enter the food supply though contaminated eggs and meat (Johnson et al., 
2009; as reviewed by Lutful Kabir, 2010; Sams, 2001), generating a path for human 
exposure.  APEC has zoonotic potential, demonstrated by common virulence factors 
(Moulin-Schouleur et al., 2006; Rodriguez-Siek et al., 2005), genome similarities to human 
extraintestinal E. coli (Johnson et al., 2007), and capacity to cause disease in animal models 
(Tivendale et al., 2010).  As such, APEC has been implicated as a possible source of E. coli 
responsible for urinary tract infections and meningitis in humans (Ewers et al., 2007; 
Rodriguez-Siek et al., 2005).   
 There is increasing pressure to reduce antimicrobial usage in livestock production.  
Other methods to maintain healthy, disease-free populations, such as enhanced host genetic 
resistance, have become a topic of great interest.  Previous research has demonstrated the 
potential for genetic resistance to disease in poultry (Kramer et al., 2003; Schou et al., 2003).  
Greater understanding of host response to infection and resulting pathology will allow 
researchers to identify the genes that best convey protection. 
 The spleen is involved in both the humoral and cellular immune responses through its 
role in the generation, maturation and storage of lymphocytes (Jeurissen, 1993; Smith and 
Hunt, 2004).  Gene expression in the chicken spleen is commonly used as an indicator of 
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immune response (Lu et al., 2009; Redmond et al., 2010).  Here, we characterize the 
differences in splenic gene expression profiles between birds with mild and severe pathology, 
and of differing vaccination status over two time points in order to identify host traits that are 
associated with colibacillosis resistance. 
Methods 
Animals 
 In six replicates, 120 male non-vaccinated commercial broiler chicks were used at 1 
day of age from a local hatchery (total n = 720).  Birds were reared on wire-floored cages 
with ad libitum access to food and water, and a 22:2 hour light:dark cycle for the first 15 
days and a 16:8 hour cycle thereafter.  Half of the chicks were vaccinated with the increased 
serum survival protein (Iss) vaccine (Lynne et al., 2006), given intramuscularly, at a dose of 
0.5ml/bird, containing 2µg of vaccine and 50µg of Quil A adjuvant in phosphate buffered 
saline (PBS) at 2 weeks of age.  Non-vaccinated birds received 50µg of Quil A adjuvant in 
0.5ml PBS at 2 weeks of age via the same route.  The Iss vaccine is generated from a 
recombinant Iss protein fused to glutathione S-transferase (GST).  iss is a gene encoding the 
increased serum survival outer membrane protein that is common in many APEC serotypes 
(Johnson et al., 2006).  At 4 weeks of age, chicks were challenged with 0.1ml containing 108 
colony forming units of APEC O1, or PBS, by the intra-air sac route into the left thoracic air 
sac.  Birds were euthanized and necropsied at 2 time points, 1 day and 5 days post-challenge, 
using half of the birds on each day.  All animal research protocols were approved by the Iowa 
State University Institutional Animal Care and Use Committee. 
Lesion scoring 
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 At necropsy, lesions were characterized and scores assigned for 3 internal tissues, air 
sacs, pericardium and liver, as described by Peighambari et al. (2000).  Air sacs had a score 
range of 0 to 3, pericardium and liver had a score range of 0 to 2.  A total lesion score was 
generated from the summation of lesion scores from each of the 3 tissues, with scores 
ranging from 0 to 7.  Within each experimental replicate, the birds with the highest and 
lowest total lesion scores were designated as having mild or severe lesions.  Birds with mild 
pathology had scores ranging from 0 to 2 with an average of 0.375 while those with severe 
pathology had scores ranging from 4 to 7 with an average of 6.125.  Birds from the 
vaccinated, challenged group were not further subdivided by pathology and a bird with an 
average total lesion score for that day and experimental replicate were selected for analysis.  
Treatment groups are abbreviated by vaccination status (V for vaccinated or NV for non-
vaccinated), challenge status (C for challenged or NC for non-challenged), day of necropsy 
(D1 for 1 day post challenge or D5 for 5 days post challenge), and, where utilized, pathology 
(M for mild or S for severe). 
Bacteria 
 APEC O1 strain (O1:K1:H7) was previously isolated from the lung of a turkey that 
died due to colisepticemia (NCBI Reference Sequence: NC_008563.1).  It has been fully 
characterized and its genomic sequence is the only total APEC sequence presently in the 
public domain (Johnson et al., 2007).  It was stored in Brain Heart Infusion (BHI) broth with 
10% glycerol at -80°C.  Two days prior to bacterial challenge, APEC O1 culture was 
streaked on Luria Bertani (LB) agar and incubated overnight at 37°C.  After incubation, 10ml 
of LB broth was inoculated with an isolated colony of APEC O1 from LB agar and incubated 
overnight at 37°C with shaking.  On the day of challenge, the bacteria were pelleted by 
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centrifugation at 5000g for 15 minutes and the bacterial pellet washed 3 times with PBS.  
Bacteria were enumerated based on spectrometric reading at 600 nm, then the inoculum was 
adjusted to the desired bacterial concentration in PBS.  Counts were confirmed through serial 
dilution plating of the inocula onto MacConkey agar overnight. 
Splenic RNA isolation 
 One sample from each of the 10 treatment groups, over 4 replicates, was selected for 
RNA isolation and microarray analysis.  Spleen tissue was removed, diced and placed into 
3.5mL of RNAlater (Ambion, AM7021).  Tissues were kept at 4°C for 7 days, then excess 
RNAlater was poured off, tissue transferred to 1.5mL tube and stored in -80°C freezer.  
Isolation of RNA from spleen samples was performed using the Ambion MagMAX-96 for 
Microarrays Kit (AM1839) (Applied Biosystems, Foster City, CA).  For each sample, 25 to 
30mg of tissue was placed into 600µL of TRI Reagent Solution (Ambion).  Tissues were then 
homogenized in the TRI Reagent.  Following homogenization, 300µL of homogenate was 
processed according to manufacturer’s instructions, using the Spin Procedure.  Total RNA 
was eluted using 50µL of Elution Buffer and stored at -80°C.  Quality and quantity of total 
RNA was assessed by Nanodrop (Thermo Scientific) and agarose gel electrophoresis.  
Across all 40 samples, the average 260/280 ratio was 2.06 with a standard deviation of 0.055.  
For 12 random samples, RNA Integrity Numbers were measured using Agilent Bioanalyzer 
2100 (Agilent Technologies, Santa Clara, CA).  An average RIN of 9.21 was achieved across 
all 12 samples. 
Microarray experiments 
 Four hundred nanograms of RNA was reverse transcribed into cDNA.  During 
reverse transcription, a T7 promoter primer region was included into the cDNA.  The cDNA 
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was then transcribed back into cRNA, using T7 RNA polymerase, labeled with either Cy3 or 
Cy5 dye.  The labeled cRNA was then purified using Qiagen RNeasy Mini Kit (Qiagen Inc., 
Valencia, CA).  Labeled samples were assessed by Nanodrop for sufficient quantity and a 
minimum specificity of 8, where specificity is the concentration of the dye (pmol/µg) times 
1000 divided by the concentration of the cRNA (ng/µL). 
 Each labeled dye (825ng) was hybridized to Agilent 4x44 Chicken Microarray (Li et 
al., 2008) for 17 hours at 65°C.  Samples were arranged in a reference design, using the NV-
NC-D1 sample from each experimental replicate as the reference to which all other samples 
within the replicate were hybridized.  After hybridization, slides were washed using 
commercial Agilent Wash Buffer and Stabilization and Drying Buffer (Agilent Technologies, 
Santa Clara, CA) and scanned using GenePix 4100A scanner (Molecular Devices Inc., 
Sunnyvale, CA) 
Microarray analysis 
 Median signal intensities for each spot were background-corrected and log-
transformed.  The Locally Weighted Scatterplot Smoothing (LOWESS) procedure was used 
to correct the intensity-dependent dye bias for each 2-color array (Dudoit et al., 2002).  All 
technical control spots and any genes exhibiting an average signal to noise ratio (SNR) less 
than 3 over all 36 arrays were removed from analysis, where SNR is calculated as (median 
foreground – median background)/background SD for each dye.  Likelihood ratio tests were 
conducted in R to determine the necessity of including random effects of array position, slide 
and experimental replicate in the model.  The results of these tests showed no evidence of the 
presence of array position or slide effects and therefore only experimental replicate was 
included as a random effect.  Treatment means were parameterized (Table 1) and estimated 
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by fitting a linear mixed model to the difference of normalized signal intensities between the 
Cy3 and Cy5 channels for each array.  The fixed effects of the linear mixed model include 
the effects of challenge, vaccination, severity (mild or severe), time point and interactions 
among them using the parameterization shown in Table 1.  P values were obtained for all 
contrasts of interest and converted to q-values for false discovery rate control using the R 
package q-value that implements the method proposed by Storey and Tibshirani (2003).  The 
data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus 
(GEO) (Barrett et al., 2009; Edgar et al., 2002) and are accessible through GEO Platform 
accession number GPL6413 and Series accession number GSE25511 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE25511). 
 Functional analysis of biological processes category was carried out using the 
Database for Annotation, Visualization and Integrated Discovery (DAVID) (Huang et al., 
2009a; Huang et al., 2009b).  Lists of significant genes were analyzed against the background 
of all 24,851 genes included for further study. 
Quantitative PCR 
 Ten genes, interleukin 1 beta, interleukin 6, avian beta-defensin 2, avian beta-
defensin 6, avian beta-defensin 7, interferon gamma, toll-like receptor 2-type I, toll-like 
receptor 4, myeloid differentiation protein 2, and interleukin receptor 1-type II were utilized 
to validate microarray results.  Genes were selected based on their functions in immune 
response and significance within microarray results.  Primer sequences are listed in 
Additional File 1.  New primer sequences were designed using sequences from NCBI and 
PRIMER3 (Rozen and Skaletsky, 2000).  Individual spleen samples were run in triplicate, 
with each triplicate randomly distributed on the 96-well plate.  RNA was quantified using 
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QuantiTect SYBR Green kit (Qiagen Inc., Valencia, CA) as previously described by 
Redmond et al. (2010).  Cycle threshold (Ct) values were recorded for each sample.  Ct 
values were adjusted for starting concentration and reaction efficiency using the formula: 40 
– (Sample Mean Ct Target + (Median 28S – Sample Mean 28S) * (Slope Target / Slope 
28S)).  Values were analyzed using the Fit Model procedure in JMP software (SAS Institute 
Inc., Cary, NC).  Contrasts with significant differential expression in microarray analysis had 
fold change compared to qPCR results. 
Results  
Microarray 
 Ten groups were generated by dividing birds into vaccinated (V) and non-vaccinated 
(NV), challenged (C) and non-challenged (NC), sampled on 1 (D1) or 5 (D5) days post 
challenge, and the non-vaccinated challenged birds on both days were subdivided into mild 
(M) and severe (S) pathology (Fig. 1).  Birds were assigned to vaccination, challenge and 
time post-harvest groups a priori, and to pathology severity groups a posteriori.  Samples 
from 40 individual birds (four biological replicates from each of 10 treatment groups) were 
used for gene expression study.  After the removal of genes with low signal to noise ratio, 
24,851 genes were included for further analysis.  There was no detectible vaccination effect 
on spleen gene expression levels.  Vaccination status had, however, a significant impact on 
total lesion score on day 1 (Fig. 2a) and day 5 (Fig. 2b) (P value < 0.001), reducing the total 
lesions observed in vaccinated birds.  The number of significantly differentially expressed 
(DE) genes (q-value < 0.05) between treatment groups and NV-NC control groups were 
analyzed (Fig. 3a).  There were a large number of DE genes between NV-C severe and NV-
NC control groups on day 1 (n=1,101) and day 5 (n=1,723).  There were few DE genes 
57 
 
 
between NV-C mild and NV-NC control groups on day 1 (n=29) and (n=0) on day 5.  The 
change in gene expression over the two post-infection days was analyzed within each 
treatment group (Fig. 3b).  The NV-C severe group showed the most difference between the 
two days with 248 DE genes.  The differences between the two pathologies, NV-C mild and 
NV-C severe, were analyzed (Fig. 3c).  More DE genes were seen on day 5 (n=799) between 
pathologies than on day 1, (n=2). 
 Direction and degree of difference between treatment groups was analyzed (Fig. 4).  
Given a threshold of a minimum fold change of 1.5, there was a greater number of up-
regulated genes due to increased pathology than the number of down-regulated genes.  Visual 
comparison between multiple contrasts was generated.  When comparing the change over 
time for all treatment groups, the NV-C mild pathology group clustered with both the NV-
NC and V-NC groups; the NV-C severe pathology group and the V-C group clustered 
together (Fig. 5).  When comparing each treatment group to the NV-NC control group on 
each day, the NV-C mild group on day 5 clustered with the V-NC groups, while the NV-C 
mild group on day 1 clustered with the challenged groups (Fig. 6). 
Gene ontology analysis 
 All contrasts in which there were sufficient DE genes (n>29) were further analyzed 
for common biological processes (BP).  For GO analysis, seven contrasts had significantly 
enriched BP terms.  There were 156 unique BP terms, of which 95 were uniquely represented 
once across all 7 contrasts (See Additional Files 2, 3, 4, 5, 6, 7, 8).  Many of the repeated 
biological process terms focused on white blood cell regulation along with defense/immune 
response to bacteria, and metabolic processes.  The groups with the highest number of DE 
genes had the most biological terms common to these genes (Table 2).  In contrasting NV-C 
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severe and NV-NC control groups, on day 1 PI many biological processes were centered 
around immune and defense response, while day 5 PI heavily focused on regulation of white 
blood cells.  The two most influenced KEGG pathways were the Jak-STAT signaling 
pathway and the cytokine-cytokine receptor interaction pathway, which occurred in the 
contrast between NC-C severe and NV-NC control on day 5 and in the contrast between NV-
C severe and NV-C mild on day 5. 
Quantitative PCR validation 
 Quantitative real time PCR (qPCR) was carried out on ten significantly DE genes, 
using a subset of the same RNA samples used for microarray analysis, to confirm the results 
seen on the microarray.  Samples from vaccinated groups were not included in qPCR 
analysis due to no DE genes from vaccination effect, allowing analysis of 24 samples (4 
replicates from 6 treatment groups).  A normalizer gene, ribosomal 28S, was used to correct 
for starting template amount.  Results from qPCR validation show general agreement with 
microarray results in direction of expression and significance (Table 3). 
Discussion  
Experimental design 
 This was a novel experimental design, allowing a contrast not only between 
challenged and non-challenged individuals, but also varying degrees of pathology.  The large 
number of birds allotted into the challenged groups allowed the identification of a sufficient 
spread of lesion scores to separate pathology groups (Fig. 1).  These commercial birds were 
raised in a homogenous environment and exhibited a large spread in pathological response, 
suggesting that a mechanism other than environment, genetic variation, is responsible for the 
resistant or susceptible phenotypes and is available to select upon. 
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 The common reference design was selected for this microarray experiment.  Although 
there are loop designs that could gain some efficiency for some contrasts, the efficiency gain 
of could be eliminated in the instance of a loss of a microarray slide.  This is because a rather 
big loop would be needed for our study of 10 treatment groups and the design of the 
microarray slide with 4 arrays per 1 slide would result in a large loss of data if a slide were to 
fail.  However, reference design is very robust in this sense.  Statistical calculation also 
shows that the reference design using the most naïve group, the NC-NV-D1 group, as the 
reference provides comparable variance estimates for our contrasts of interest with the loop 
design. The common reference design was suggested by Dobbin and Simon (2002) because it 
produces better results than does a loop design for multiple comparisons and clustering 
analysis, both of which were applied in data analysis.   
Differential gene expression 
 Surprisingly, there was no significant vaccination effect on gene expression in the 
spleen.  The vaccine, however, was clearly effective in protecting the chicks, as evidenced by 
the lesion scores.  There are several variables that could contribute to no detection of DE 
genes in response to vaccination: statistical power, the tissue examined or the timeframe 
selected, in regard to age vaccinated, age challenged, and time points tissues were collected.  
Fold change calculations of these non-significant genes reveal few changes of 2 fold or 
greater, suggesting that inter-animal variation was not responsible for lack of detection of 
differential expression.  The spleen is an important immunological organ in the chicken and 
has been successfully utilized to detect differences in cytokine gene expression after 
immunization Marek’s disease vaccines and DNA vaccines (Abdul-Careem et al., 2007; 
Abdul-Careem et al., 2008; Gimeno and Cortes, 2011; Kano et al., 2009; Song et al., 2010).  
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The selection of vaccination at 2 weeks of age has also been successfully utilized to detect 
splenic expression differences (Abdul-Careem et al., 2008), with several other vaccination 
times used successfully: day 18 of incubation, 1 day of age, and 2 weeks of age with a 4 
week booster (Abdul-Careem et al., 2007; Gimeno and Cortes, 2011; Kano et al., 2009; Song 
et al., 2010).  The time period selected between immunization and sampling can greatly 
impact the ability to detect expression differences, with later sampling times, 10 days post 
vaccination, showing reduced expression differences compared to earlier sampling times 
(Abdul-Careem et al., 2008; Gimeno and Cortes, 2011), though detection 26 days post 
vaccination is still possible (Kano et al., 2009).  It is likely that the selection of 1 and 5 days 
post challenge, 15 and 20 days after initial vaccination, was not optimal for expression 
discovery in the spleen utilizing an Iss vaccine. 
 There were more DE genes in the NV-C severe group than the V-C group on both 
days when contrasted against NV-NC control.  Analysis of host-pathogen interaction genes 
(Kano et al., 2009) and cytokines (Abdul-Careem et al., 2007) in response to Marek’s 
Disease virus challenge revealed more DE genes in the spleens of non-vaccinated birds than 
vaccinated.  This trend was again seen in birds challenged with Salmonella Enteritidis in the 
cecum of vaccinated and non-vaccinated birds (Carvajal et al., 2008).  Non-vaccinated birds 
that receive a pathogen challenge may rely more on significant changes in gene regulation to 
fight off bacteria than vaccinated birds.  The greater amount of DE genes detected may also 
be attributed to the selection of average lesioned birds for representatives of the V-C group, 
though the number of DE genes is still a small fraction of that generated by the severe group. 
 Effect of APEC challenge on splenic gene expression varied with level of pathology.  
The contrasts in which there were the largest numbers of DE genes involved the NV-C 
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severe group.  Severe pathology may produce the largest changes in gene expression levels 
making them easier to detect, as observed with serum cytokine levels (Sevimli et al., 2008).  
The NV-C mild group varied little from the NV-NC control, suggesting that the bacteria may 
have been cleared and the bird returned to homeostasis by day 5, while still exhibiting a 
small response on day 1.  In contrast, the number of DE genes increased from day 1 to day 5 
in the NV-C severe group compared to the NV-NC control.  Past studies utilizing Salmonella 
and two distinct genetic populations illustrated differences in gene expression patterns 
between mild and severe pathologies unique to a genetic background (Zhou and Lamont, 
2007), demonstrating the importance of assessing responses in lines of interest, such as a 
commercial line used in this study, for potential application.  Commercial type birds, broiler 
chickens and broiler x Leghorn chickens, noted the same increase in gene expression over 
time under severe pathology, while chickens with a more robust chicken background, broiler 
x Fayoumi, had fewer DE genes that decreased over time under severe pathology (Zhou and 
Lamont, 2007).  Due to the clear difference in number of DE genes seen between either NV-
C mild or NV-C severe and the NV-NC control group, it is unusual that there is not a higher 
number of DE genes detected between the NV-C mild and NV-C severe groups on day 1.  
Levels of serum amyloid A and cytokines showed a linear trend between control, mild, 
moderate and severe conditions (Sevimli et al., 2008).  This suggests that this is the trend for 
splenic gene expression level between NV-NC control, NV-C mild and NV-C severe groups.  
This intermediate expression could make it more difficult to detect expression differences, 
while the large expression level changes in the NV-C severe group make it easy to detect 
them against NV-NC control. 
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 At both tissue harvest times, more genes increased expression in challenged groups 
compared to NV-NC control groups (55-78%) and more increased in severe compared to 
mild pathology group on day 5 (66%).  Bacterial challenge has been demonstrated to cause 
more gene induction than repression (Zhou and Lamont, 2007), particularly within cytokines 
(Brisbin et al., 2010).  Direction stayed consistent for genes that were significant on both 
days.  Of the genes that were differentially expressed in NV-C severe compared to NV-NC 
control on both days, 385 of 387 were in the same direction of regulation and all 6 DE genes 
on both days in the V-C groups were in the same direction of regulation. 
 In generation of the heatmaps, genes included were largely driven by the NV-C 
severe group, requiring a minimum q-value of 0.05 across all contrasts included.  Comparing 
the change over time for each treatment group (Fig. 5), groups clustered as expected based on 
earlier contrast comparisons.  The NV-C mild pathology group showed little difference 
compared to NV-NC control and also showed more similar expression pattern changes to the 
V-NC group than to the NV-C severe and V-C group.  As expected, both the NV-NC and the 
V-NC groups exhibit minimal changes of 2 fold or greater, further illustrating the lack of 
expression changes over time without a pathogen stimulus.  When comparing each treatment 
with the NV-NC control (Fig. 6), the NV-C mild group on day 1 was most similar to the 
other challenged groups, while on day 5 it clustered with non-challenged groups, supporting 
the hypothesis of returning to homeostasis, or a non-challenged state, by day 5.  Contrasts 
that represented the same day post challenged clustered together, demonstrating strong 
similarities in expression changes over time among groups. 
Gene ontology investigation 
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 The advantage of utilizing a global microarray is the potential to investigate and 
discover a wide range of gene ontology (GO) terms hidden within the dataset.  Although it is 
difficult to differentiate cause and effect in gene expression in a pathogen challenge, 
functional terms enriched in the biological processes may grant some insights.  Terms related 
to immune response, regulation of immune related cells, and metabolic processes commonly 
appeared in contrasts involving the NV-C severe group on both days or V-C group on day 1, 
consistent with bacterial infection as detected in multiple tissues (Lan et al., 2010; Li et al., 
2010; Tsai et al., 2010; Zhou et al., 2009).   
 The NV-C severe group on day 1 had many terms related to response to bacteria, 
inflammation and circulatory processes, along with a few receptor signaling terms.  Particular 
genes among these groups included the avian beta-defensins, known peptides with 
antimicrobial activity that have demonstrated induction patterns in various tissues in response 
to E.coli derived lipopolysaccharide and Salmonella (Meade et al., 2009; Milona et al., 2007; 
Subedi et al., 2007).  Toll-like receptors (TLR) recognize conserved molecular patterns 
common to many pathogens.  Changes in TLR expression, in response to bacterial infection, 
have also been demonstrated (Lu et al., 2009; Abasht et al., 2009).  Induction of pro-
inflammatory response after pathogen challenge is common (Jarosinski et al., 2005).  The 
changes seen in inflammation and circulatory processes may be responsible for observed 
lesion phenotype.   
 At day 5, many of the terms found in the NV-C severe group had changed, focusing 
more on regulation of white blood cells, localization and transport, with lesser emphasis on 
metabolic and biosynthetic processes than day 1.  The severe status of these birds may be 
attributed to a slower response by these defense mechanisms.  Cytokines and chemokines 
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help signal white blood cells and attract them to sites of infection.  Many cytokines have 
reported expression differences in less than 5 days post infection (Kim et al., 2008; Zhou et 
al., 2009).  The main detectable differences between NV-C mild and NV-C severe groups on 
day 5 involved response mechanism and regulation of WBC.  The Jak-STAT and cytokine-
cytokine receptor interaction pathways have several overlapping elements, 6 and 9 
overlapping elements in contrasts of NV-C severe vs. NV-C mild on day 5 and NV-C severe 
vs. NV-NC control on day 5 respectively.  Bacterial infection has previously noted changes 
in the Jak-STAT pathway in granulosa cells (Tsai et al., 2010) and cecal tissue (Li et al., 
2010).  Changes in genes in these pathways have also been discovered in spleen after 
Clostridium infection: signal transducer and activator of transcription, growth factor 
receptor-bound protein, cytokines and cytokine receptor genes (Zhou et al., 2009). 
 The low number of DE genes found between several contrasts of interest limited GO 
analysis.  Only one biological process term was significantly enriched in two contrasts 
examined: intracellular signaling cascade, between NV-C mild and NV-NC control groups 
on day 1 and transcription, between V-C and NV-NC control on day 5.  As with many 
current microarrays, annotation has limited the extent of GO analysis, illustrating the urgent 
need to increase our knowledge in gene functions of genome sequences which have been 
discovered (van den Berg et al., 2010). 
Conclusions  
 There is a large difference in splenic transcriptome profiles between birds with mild 
and severe lesions in response to APEC infection, revealing gene networks potentially 
associated with disease resistance.  The response of birds with severe lesions is much larger, 
both in magnitude and number of differentially expressed genes, than birds with mild lesions.  
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Time post-challenge with APEC also resulted in significant differences in gene expression.  
Few differences were detected between the NV-C mild group and NV-NC control at day 1 
and zero at day 5, suggesting that immune response to APEC was very rapid, occurring 
before day 1 sampling, or involved few detectable gene expression changes.  Vaccination 
generated an efficacious protective effect, but no expression differences were detected at 2 
weeks post vaccination.  The gene ontology terms found within uniquely differentially 
expressed genes of birds with severe lesions helped provide insight into what genes are 
different as well as the overall processes defined by those genes.  Changes in the Jak-STAT 
pathway and cytokine-cytokine receptor signaling highlight the importance of proper 
signaling cascades to fight infection.  The results from this study add greater depth to the 
knowledge base about chicken host response to APEC. 
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Table 1 - Parameterization of treatment groups 
Group Parameterization  
NV-NC-D1  µ  
NV-NC-D5  µ + τ
1
  
NV-C-D1-M  µ + β  
NV-C-D5-M  µ + β + λ  
NV-C-D1-S  µ + β + γ  
NV-C-D5-S  µ + β + λ + γ + θ  
V-NC-D1  µ + α  
V-NC-D5  µ + α + τ
2
  
V-C-D1  µ + α + β + φ  
V-C-D5  µ + α + β + φ + τ
3
  
 
 
Table 2 - Number of GO biological terms found in each contrast 
Number of differentially expressed (DE) genes found between contrasts of interest and the 
number of biological terms found using those genes. 
Contrast DE Genes Biological Terms 
NV-C Mild Day 1 vs. NV-NC Control Day 1 29 2 
NV-C Severe Day 1 vs. NV-NC Control Day 1 1101 27 
NV-C Severe Day 5 vs. NV-NC Control Day 5 1723 73 
V-C Day 1 vs. NV-NC Control Day 1 182 27 
V-C Day 5 vs. NV-NC Control Day 5 137 1 
NV-C Severe Day 1 vs. NV-C Severe Day 5 248 4 
NV-C Severe Day 5 vs. NV-C Mild Day 5 799 63 
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Table 3 - Quantitative PCR validation 
Log2 fold change between contrasts presented.  + values indicate higher expression in the 
first group, - values indicate higher expression in the second group.  **  P value < 0.05 in 
qPCR, q-value < 0.05 in microarray, * P value < 0.10 in qPCR 
Gene  Contrast  qPCR  Microarray  
AvBD 2  NV-C Severe Day 5 vs. NV-C Mild Day 5 -3.035*  -2.038**  
 NV-C Severe Day 1 vs. NV-NC Control Day 
1  
2.954**  1.552**  
 NV-C Severe Day 5 vs. NV-NC Control Day 
5 
-3.206**  -1.863**  
 NV-C Severe Day 1 vs. NV-C Severe Day 5  5.525**  2.931**  
AvBD 6  NV-C Severe Day 1 vs. NV-NC Control Day 
1 
2.592**  1.719**  
 NV-C Severe Day 1 vs. NV-C Severe Day 5 4.726**  2.194**  
AvBD 7  NV-C Severe Day 5 vs. NV-C Mild Day 5 -4.259  -3.440**  
 NV-C Severe Day 1 vs. NV-NC Control Day 
1 
1.214  1.731**  
 NV-C Severe Day 1 vs. NV-C Severe Day 5 4.446*  3.346**  
IL1B  NV-C Mild Day 1 vs. NV-NC Control Day 1  0.567  3.826**  
 NV-C Severe Day 1 vs. NV-NC Control Day 
1 
1.290  1.836**  
 NV-C Severe Day 5 vs. NV-NC Control Day 
5 
2.296  1.960**  
IL6  NV-C Severe Day 5 vs. NV-C Mild Day 5 2.263  1.117**  
 NV-C Severe Day 1 vs. NV-NC Control Day 
1 
3.027* 1.227**  
 NV-C Severe Day 5 vs. NV-NC Control Day 
5 
2.611  1.138**  
IFNG NV-C Severe Day 5 vs. NV-C Mild Day 5 2.399**  1.154**  
 NV-C Severe Day 5 vs. NV-NC Control Day 
5 
2.427**  2.000**  
TLR 2  NV-C Severe Day 1 vs. NV-NC Control Day 
1 
-0.070  1.140**  
 NV-C Severe Day 5 vs. NV-NC Control Day 
5 
0.699  0.984**  
TLR 4  NV-C Severe Day 5 vs. NV-NC Control Day 
5 
1.396*  1.336**  
MD-2  NV-C Severe Day 5 vs. NV-C Mild Day 5 0.028  5.311**  
 NV-C Severe Day 5 vs. NV-NC Control Day 
5 
0.034  1.230**  
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Table 3 (continued) 
Gene  Contrast  qPCR  Microarray  
IL1-R, type 
II  
NV-C Severe Day 1 vs. NV-C Mild Day 1  1.574 ** 1.263**  
 NV-C Severe Day 1 vs. NV-NC Control Day 
1 
1.241  2.676**  
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Figure 1 – Experimental design 
Flow chart of experimental design and 10 treatment groups showing how bird numbers 
within each replicate were placed into each of the 10 treatment groups 
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Figure 2 - Total lesion score distribution 
Comparison of the distribution of lesion scores of challenged birds taken on day 1 between 
birds that received the vaccine and birds that did not receive the vaccine for all 4 replicates 
on (a) day 1 and (b) day 5 (P<0.001) 
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Figure 3 – Significantly differentially expressed genes for contrasts of interest 
Number of significantly differentially expressed genes between (a) treatment and control 
groups, (b) day 1 and day 5 within treatment, and (c) mild and severe groups (q-value < 0.05) 
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Figure 4 – Direction of response 
Directionality of significantly differentially expressed genes found in various contrasts with a 
minimum fold change of 1.5.  For each contrast, up-regulated means there is greater 
expression in the first group, down-regulated means there is greater expression in the second 
group listed (q-value < 0.05) 
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Figure 5 - Heatmap comparison of day 1 and day 5 
Visual representation of log2 fold change differences for all treatment groups between day 1 
and day 5.  Genes included were significant in at least one contrast presented (q-value < 
0.05).  Positive fold change indicates greater expression on day 5. 
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 Figure 6 - Heatmap comparison of treatments and controls 
Visual representation of log2 fold change differences between all treatment groups and day 
appropriate NV-NC control.  Genes included were significant in at least one contrast 
presented (q-value < 0.05).  Positive fold change indicates greater expression in treatment 
group. 
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Additional files 
Additional file 1 – Primers utilized for qPCR analysis 
Forward and reverse primer sequences used for quantitative PCR analysis. 
Primer Forward Sequence  (5’-3’) 
Reverse Sequence  
(5’-3’) Reference 
AvBD2 TTTCTCCAGGGTTGTCTTCG 
AGCAGCTTCCGACTTT
GATT Designed for Current Study 
AvBD6 TGCAGGTCAGCCCTACTTTT 
GTCCACTGCCACATGA
TCC Designed for Current Study 
AvBD7 CTGCTTTCCAGGGATCTGTC 
GCCAGAGAAGCCATTT
GGTA Designed for Current Study 
IL1β GCTCTACATGTCGTGTGTGATGAG 
TGTCGATGTCCCGCAT
GA 
Withanage et al., 2004 Infection 
and Immunity, 72:2152-2159. 
IL6 GCTCGCCGGCTTCGA GGTAGGTCTGAAAGGCGAACAG 
Kaiser et al., 2000 Microbiology, 
146:3217-3226. 
IFNγ GTGAAGAAGGTGAAAGATATCATGGA 
GCTTTGCGCTGGATTC
TCA 
Kaiser et al., 2000 Microbiology, 
146:3217-3226. 
TLR2 CCGGTGCTTCATTCACAGAT 
CATATCCCATGCTCCT
TTCC Designed for Current Study 
TLR4 GGATCTTTCAAGGTGCCACA 
CAAGTGTCCGATGGGT
AGGT 
Abasht et al., 2008 Veterinary 
Immunology and 
Immunopathology, 123:314-323 
MD2 ATGAAGCATCCCACCCAATA 
AATGAGCTGAAGAATC
ACAAAAAGT Designed for Current Study 
IL1R TCCAGTGGTACAAGGATGCTC 
GCCGGAGTCTGTCGGT
AATA Designed for Current Study 
28S GGCGAAGCCAGAGGAAACT 
GACGACCGATTTGCAC
GTC 
Kaiser et al., 2000 Microbiology, 
146:3217-3226. 
 
Additional file 2 – Excel file – Mild vs. Control, Day 1 
Results of DAVID analysis of significant genes using a custom background of genes 
included in the microarray analysis.  Results presented are of the Biological Processes ALL 
category
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Additional file 3 – Excel file – Severe vs. Control, Day 1 
Results of DAVID analysis of significant genes using a custom background of genes 
included in the microarray analysis.  Results presented are of the Biological Processes ALL 
category 
 
Additional file 4 – Excel file – Severe vs. Control, Day 5 
Results of DAVID analysis of significant genes using a custom background of genes 
included in the microarray analysis.  Results presented are of the Biological Processes ALL 
category 
 
Additional file 5 – Excel file – Vaccinated Challenged vs. Control, Day 1 
Results of DAVID analysis of significant genes using a custom background of genes 
included in the microarray analysis.  Results presented are of the Biological Processes ALL 
category 
 
Additional file 6 – Excel file – Vaccinated Challenged vs. Control, Day 5 
Results of DAVID analysis of significant genes using a custom background of genes 
included in the microarray analysis.  Results presented are of the Biological Processes ALL 
category 
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Additional file 7 – Excel file – Severe vs. Mild, Day 5 
Results of DAVID analysis of significant genes using a custom background of genes 
included in the microarray analysis.  Results presented are of the Biological Processes ALL 
category 
 
Additional file 8 – Excel file – Severe Day 1 vs. Severe Day 5 
Results of DAVID analysis of significant genes using a custom background of genes 
included in the microarray analysis.  Results presented are of the Biological Processes ALL 
category 
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Abstract 
 Avian pathogenic Escherichia coli (APEC) causes colibacillosis, which is responsible 
for morbidity, mortality and condemnation of processed birds, and is a human health risk. 
Genetic selection to increase host immune response is a promising method to reduce reliance 
on antimicrobial therapy.  This approach requires in depth knowledge of what constitutes and 
controls a successful response.  Broiler chicks were experimentally vaccinated at 2 weeks of 
age and challenged at 4 weeks of age with APEC.  At 1 and 5 days post-infection, whole 
blood was collected and peripheral blood leukocytes isolated.  Gross lesions in the air sacs, 
pericardium and liver at necropsy were used to assign pathology category, either mild or 
severe, to non-vaccinated, challenged chicks.  Ten treatment groups were classified with a 
priori factors of vaccination status, challenge status, day post-infection, and a posteriori 
factor of pathology.  The transcriptome of blood leukocytes was evaluated utilizing a chicken 
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44K Agilent microarray.  Large numbers of expression differences occurred in 4 pair-wise 
contrasts, all of which included the severe pathology groups.  More genes were up-regulated 
than down-regulated in response to infection.  There was no detectible vaccination effect, 
despite a significant reduction in total gross lesions in vaccinated chicks.  Gene ontology 
analysis of significant genes revealed enrichment of immune response and metabolic 
processes. This study not only analyzed the effect of vaccination and challenge on 
transcriptomic response, but also investigated the differences in host response associated with 
mild and severe outcomes of colibacillosis, providing the framework for future studies on 
genetic resistance to APEC. 
Introduction 
 Avian pathogenic Escherichia coli (APEC) are a subpathotye of extraintestinal 
pathogenic E. coli (ExPEC) that cause extraintestinal diseases in poultry that are collectively 
known as colibacillosis.  APEC may also be a food safety concern, with current research 
showing strong genetic similarities between APEC and human ExPEC (Johnson et al., 2007; 
Moulin-Schouler et al., 2006; Rodrigues-Siek et al., 2005a).  These similarities suggest 
zoonotic potential for APEC and APEC as a source for human ExPEC virulence genes 
(Ewers et al., 2007; Jakobsen et al., 2010; Rodrigues-Siek et al., 2005a).  Recently, APEC 
has been shown to cause disease in a rat model for human meningitis (Tivendale et al., 2010).  
Through horizontal and vertical transmission, APEC can cause disease and death in infected 
birds, resulting in large monetary losses through condemnation of carcasses and reduced 
production (Barnes et al., 2008; Bisaillon et al., 1988; Russell, 2003).  Though there are 
many serogroups of APEC that cause disease in birds (Barnes et al., 2005; Rodrigues-Siek et 
al., 2005b), O1 has been a focal point for study of pathogen and host response to infection, as 
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it is one of the major serogroups responsible for colibacillosis worldwide (as reviewed by 
Dziva and Stevens, 2008).  In addition, APEC O1 is one of the most well characterized 
APEC strains in the literature (Johnson et al., 2007; Li, G. et al., 2011). 
 Antimicrobials are commonly used to control colibacillosis in the poultry industry.  
With rising concern and demonstration of drug resistant bacteria (as reviewed by Lutful 
Kabir, 2010), other control methods, such as enhanced host genetics, are a growing area of 
research.  Past experimentation has illustrated the potential for breeding for colibacillosis 
resistance (Ask et al., 2006; Cavero et al., 2009), indicating that greater research surrounding 
the mechanisms of resistance is needed as a foundation for more effective breeding  
programs.  Gene expression analysis of immune tissues is commonly used to characterize 
immune response (Chiang et al., 2008; Redmond et al., 2009) and provides potential 
candidate genes for disease resistance.  Gene expression levels of immune genes have been 
shown to be heritable (Swaggerty et al., 2008), evidence that this tactic could be successful in 
a breeding program.   
 The chicken immune system is equipped with several mechanisms to combat 
pathogens.  Peripheral blood leukocytes (PBL) are comprised of a diverse group of cell types 
that serve in both the innate and adaptive immune responses (Erf, 2004; Sharma, 2008).  
Heterophils, the avian equivalent of neutrophils, are an innate responder and typically the 
first cell type to fight infection.  Heterophils destroy susceptible bacteria through 
phagocytosis, oxidative burst and extracellular traps (Chuammitri et al., 2009; Farnell et al., 
2006).  Proper signaling by cytokines and T-helper cells can increase the effectiveness of 
immune response.  The defensive mechanisms of APEC can, however, reduce the 
effectiveness of the innate immune response and may include resistance to the detrimental 
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effects of phagocytosis and complement, or decreasing the antimicrobial activity of 
heterophils (Harmon, 1998; Kottom et al., 1997; Mellata et al., 2003; Nolan et al., 2003; 
Qureshi, 2003).  Enhanced genetics of the host immune response may allow chickens to 
overcome APEC’s defenses.  This study reports genes expression differences in PBL due to 
challenge status and pathology differences, identifying factors that contribute to a successful 
host response to APEC challenge. 
Materials and Methods 
Ethics Statement 
 All animal research protocols were performed under animal biosafety level 2 
protocols and were approved by the Iowa State University Institutional Animal Care and Use 
Committee (approval # 11-07-6460-G). 
Bacteria Preparation 
 APEC O1 strain O1:K1:H7 (NCBI Reference Sequence: NC_008563.1) was kept in 
Brain Heart Infusion (BHI) broth with 10% glycerol at -80°C.  Its genomic sequence is 
available and has been completely characterized (Johnson et al., 2007).  Two days prior to 
bacterial challenge, bacteria were removed from the freezer and streaked onto Luria Bertani 
(LB) agar then incubated overnight at 37°C.  An isolated colony was then placed into 10 ml 
of LB broth and incubated overnight at 37°C with shaking.  On day of APEC challenge, 
bacteria were pelleted by centrifugation at 5000xg for 15 minutes.  The pellet was then 
washed in phosphate buffered saline (PBS) 3 times before being enumerated by 
spectrometric reading at 600 nm.  The inoculum was adjusted to the desired bacterial 
concentration, and counts were confirmed through serial dilution plating onto MacConkey 
agar overnight. 
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Animal Experiments 
 Non-vaccinated, commercial male broiler chicks were purchased at 1 day of age from 
a local hatchery.  In six replicates, 720 birds (120 per replicate) were raised on wire-floor 
cages with ad libitum access to food and water.  Challenged birds were housed separately 
from non-challenged birds.  At 2 weeks of age, 50% of the chicks were intramuscularly 
vaccinated with 0.5ml/bird of Iss vaccine (Lynne et al., 2006), containing 2µg of vaccine and 
50µg of Quil A adjuvant in PBS.  Non-vaccinated chicks received 50µg of Quil A adjuvant in 
PBS via the same route.  Increased serum survival, iss, encodes an outer membrane 
lipoprotein and is a virulence factor common to most APEC serotypes (Johnson et al., 2006; 
Pfaff-McDonough et al., 2000; Rodrigues-Siek et al., 2005b).  At 4 weeks of age, 80% of the 
chicks, half vaccinated and half non-vaccinated, were challenged with 0.1ml containing 108 
colony forming units of APEC O1 injected into the left thoracic air sac.  Non-challenged 
chicks received 0.1ml of PBS via the same route.  Birds were sampled and euthanized at 2 
time points, 1 and 5 days post-infection (PI), equally splitting birds within each group 
between the two times.   
 Blood samples were collected from the jugular vein into 5mL vacuum tubes 
containing EDTA and placed on ice until PBL isolation.  Birds were then euthanized and 
internal lesion scores assigned for 3 tissues, air sacs, pericardium and liver, as described by 
Peighambari et al. (2000).  Scores from 0 to 2 were assigned for pericardium and liver; scores 
from 0 to 3 were assigned for air sacs.  A summation of all 3 lesions scores for each 
individual bird was used to generate a total lesion score.  Non-vaccinated, challenged birds 
were split into two pathology categories based upon total lesion score: mild and severe.  
Birds with low lesion scores were used to represent mild pathology, with an average lesion 
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score of 0.375, and those with high lesion scores were used to represent severe pathology, 
with an average lesion score of 6.125.  Ten treatment groups were generated from vaccinated 
(V) or non-vaccinated (NV), challenged (C) or non-challenged (NC), day 1 or day 5 necropsy 
treatments and 2 pathological categories of mild and severe within the non-vaccinated, 
challenged groups (Figure 1).   
PBL Isolation 
 PBL were separated from whole blood samples.  Phosphate buffered saline was 
combined with approximately 1-3 ml of blood sample to a total volume of 10 ml.  A 
Histopaque 1077/1119 (Sigma Aldrich, St. Louis, MO) discontinuous gradient was created 
by placing 10 ml of Histopaque 1119 into a 50 ml tube, overlaying 10 ml of Histopaque 
1077, then overlaying 4 ml of blood/PBS mixture.  The gradient mixture was centrifuged at 
700xg for 30 min at room temperature.  Cell layers were removed from the 
plasma/Histopaque 1077 interface (mononuclear cells) and from the 1077/1119 interface 
(heterophils) with a Pasteur pipette, combined and transferred to a 15 ml tube.  Cells were 
washed by adding 6 ml of PBS and centrifuged at 600xg for 10 min at room temperature.  
Supernatant was discarded and the cell pellet washed a second time with PBS.  Supernatant 
was discarded and PBL resuspended in 1.5 ml of RNAlater (AM7021) (Applied Biosystems, 
Foster City, CA).  Cells were refrigerated in RNAlater for 7 days then excess RNAlater was 
decanted and cells were stored at -80°C until RNA isolation. 
RNA Isolation 
 RNA samples were isolated using the Ambion MagMax-96 kit for Microarrays 
(AM1839) (Applied Biosystems, Foster City, CA).  Briefly, PBL were added to 0.6 ml of 
TRI Reagent Solution (Ambion, Austin, TX).  Samples were homogenized and split into two 
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300 µl aliquots, with 1 aliquot further processed and the other held in reserve.  Samples were 
then processed using the Spin Procedure according to manufacturer’s instructions.  Total 
RNA was eluted with 30 µl of Elution Buffer and stored at -80°C.  Quality and quantity of 
RNA were assessed by Nanodrop (Thermo Scientific, West Palm Beach, FL). 
Microarray Experiments 
 Gene expression was assessed utilizing the global 2-color chicken 44K Agilent 
Microarray (Li et al., 2008).  A total of 40 samples, one from each of 4 experimental 
replicates of 10 treatment groups, were hybridized to the microarray in a reference design, 
using the NV-NC-day 1 sample as the reference for each experimental replicate, on 36 
arrays.  Within each replicate, the NV-NC-day 1 sample was hybridized to the other 9 
treatment groups.  Dye assignments were swapped between replicates.  Briefly, 400 ng of 
total RNA was reverse transcribed into cDNA with a T7 promoter region incorporated, then 
transcribed back into cRNA labeled with either Cy3 or Cy5 dye.  Before hybridization, 825 
ng of each labeled sample, Cy3 and Cy5, a blocking agent and fragmentation buffer were 
mixed together and incubated for 30 minutes at 60°C.  Following incubation, gex 
hybridization buffer was added and samples were hybridized to the microarray slide for 17 
hours at 65°C.  After hybridization, slides were washed in Agilent Wash Buffer, Acetonitrile, 
and Stabilization and Drying Buffer (Agilent Technologies, Santa Clara, CA) then scanned 
using GenePix 4100A scanner and GenePix Pro software (Molecular Devices Inc., 
Sunnyvale, CA). 
 The median backgrounds were subtracted from the median Cy3 and Cy5 foreground 
intensity reads for each spot and were log2-transformed.  Technical control spots and spots 
exhibiting an average signal to noise ratio of less than 3 over all 36 arrays were excluded 
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from further analysis.  Signal to noise ratios were calculated as (median foreground – median 
background)/background standard deviation for each dye.  Locally Weighted Scatterplot 
Smoothing (LOWESS) procedure was utilized to correct for intensity dependent dye bias 
(Dudoit et al., 2002).  A linear mixed model approach was used to estimate treatment means 
by fitting the difference of Cy3 and Cy5 normalized signal intensities with each treatment 
groups’ parameterization for each gene as described by Sandford et al. (2011).  Only one 
random effect, experimental replicate, was included in the model, as likelihood ratio testing 
determined no effect of slide or array position.  P values were obtained for contrasts of 
interest.  False discovery rate was controlled by converting P values to q values using the R 
package qvalue (Story and Tibshirani, 2003).  Gene ontology analysis of biological processes 
for significant genes was performed using the Database for Annotation, Visualization and 
Integrated Discovery (DAVID) (Huang et al., 2009a, Huang et al., 2009b). 
Quantitative PCR Validation 
 Quantitative real time PCR (qRT-PCR) was performed as described by Redmond et 
al. (Redmond et al., 2009) to confirm microarray results.  The following fifteen genes were 
selected because of significance in the microarray study: clusters of differentiation (CD) 3ε, 
CD4, CD5, CD28, toll-like receptors (TLR) 7, TLR15, TLR21, heat shock protein 70 
(HSP70), P20K, Rab11a, avian beta-defensins (AvBD) 2, AvBD4, AvBD5, AvBD6, and 
AvBD7.  28S was utilized as a housekeeping gene to normalize for starting concentration of 
RNA.  Primer sequences for CD4, CD5, TLR7, Rab11a, AvBD2, AvBD4, AvBD5, AvBD6, 
and AvBD7 were designed using sequences from NCBI and PRIMER3 (Rozen and 
Skaletsky, 2000).  Primer sequences for 28S, TLR15, and TLR21 have been previously 
reported (28S (Kaiser et al., 2000); TLR15 (Higgs et al., 2006); TLR21 Brownlie et al., 
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2009)).  CD3ε, CD28, and P20K were previously utilized (Zhou and Lamont, 2007) but 
primer sequences were not published.  All unpublished primer sequences can be found in 
Table 1.  Each sample was run in three wells.  Cycle threshold (Ct) values were recorded for 
each well and each sample triplicate was averaged.  Slopes representing reaction efficiency 
for each gene were generated through amplification of a serial dilution.  CT values were 
adjusted for RNA concentration and reaction efficiency using the formula: 40 – [Sample 
Meant CT Target Gene + (Median 28S for All Samples – Sample Mean 28S) * (Slope Target 
Gene / Slope 28S)].  Adjusted Ct values were analyzed using the Fit Model procedure in JMP 
software (SAS Institute Inc., Cary, NC).  Validation was carried out utilizing RNA extracted 
from different birds than those included in the microarray analysis representing the same 
treatment groups and replicates, allowing for both technical and biological replication.   
Microarray Data Accession Number 
 The microarray data for this experiment have been deposited in NCBI’s Gene 
Expression Omnibus (GEO) (Barrett et al., 2009; Edgar et al., 2002) database and are 
accessible through the series accession GSE31387 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31387). 
Results 
Transcriptome Analysis of PBL 
 Forty individual samples were analyzed by microarray; 1 bird from each of 10 
treatment groups, with 4 replications.  After removal of spots with a signal to noise ratio less 
than 3, a total of 24,387 genes were included in the statistical analysis.  Effects of treatment 
were analyzed through contrasts of treatment groups.  Contrasts measured tested effect of 
time for each treatment group, comparisons of each group to control, effect of vaccination, 
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and effect of pathology.  Large numbers (>100) of significantly differentially expressed 
genes (q value < 0.05) were detected in 4 contrasts of interest, all involving the NV-C severe 
groups.  The largest number of differentially expressed genes (1,914 genes) was found in the 
contrast of NV-C severe day 5 vs. NV-C mild day 5.  The second largest number of 
differentially expressed genes (1,097 genes) was found in the contrast of NV-C severe group 
vs. NV-NC control group on day 1.  This number was reduced to 506 differentially expressed 
genes for the same contrast on day 5.  The number of differentially expressed genes in the 
contrast of NV-C severe day 1 vs. NV-C severe 5 was 107 genes. 
 Numbers of shared and unique differentially expressed genes between 3 contrasts 
analyzing differences in treatment group on the same day are displayed in Figure 2.  A total 
of 417 differentially expressed genes found in the contrast of NV-C severe day 5 vs. NV-NC 
control day 5 were also differentially expressed in the NV-C severe day 5 vs. NV-C mild day 
5 contrast; 280 genes had increased expressed in the severe group in both contrasts, 137 
genes had decreased expressed in the severe group in both contrasts.  In all of the shared 
genes between the contrasts represented in Figure 2, 99% of genes were expressed in the 
same direction relative to the severe group; either all more highly expressed in the severe 
group across all contrasts or more lowly expressed among all contrasts. 
 The differences between internal lesion scores of vaccinated and non-vaccinated, 
challenged birds were tested through two-sample t-tests for each day.  There was a 
significant (P value < 0.001) reduction in internal lesions among vaccinated, challenged birds 
compared to those non-vaccinated, challenged birds on both days, however, no differentially 
expressed genes due to vaccination effect were detected.  On day 1, the mean±standard 
deviation of lesion scores for vaccinated birds was 1.50±1.27 (N=76) and unvaccinated birds 
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3.06±1.68 (N=87).  On day 5, the mean±standard deviation of lesion scores for vaccinated 
birds was 2.94±2.08 (N=80) and unvaccinated birds 4.28±1.94 (N=85).  Vaccination effect 
on gene expression was tested both through the V-NC group vs. NV-NC contrast on both 
days and through a contrast utilizing a combination of all treatment groups, non-challenged 
and challenged, on both days. 
 Samples from individuals with severe pathology or collected 5 days post-infection 
exhibited more gene induction than repression.  Of differentially expressed genes with a 
minimum fold change of 1.5, 60-80% of genes exhibited induction in the 4 contrasts that 
include: NV-C severe day 5 vs. NV-C mild day 5, NV-C severe day 1 vs. NV-NC day 1, NV-
C severe day 5 vs. NV-NC day 5, NV-C severe day 1 vs. NV-C severe day 5.  Many 
differentially expressed genes showed large fold changes.  In the 4 contrasts described, 25-
31% of differentially expressed genes had a fold change of 3 or greater.   
 Heatmaps were generated to characterize patterns of gene expression between similar 
contrasts by including genes with a minimum q value of 0.05 in any contrast (Figures 3 and 
4).  The NV-C mild group on day 5 showed more similarities to the V-NC groups than to the 
challenged groups (Figure 3).  The remaining challenged groups, both vaccinated and non-
vaccinated, exhibited similar expression patterns.  The only group with notable expression 
changes over time was the NV-C severe group (Figure 4). 
Gene Ontology Analysis of Significant Genes 
 Gene ontology analysis focused on biological process terms among significant genes.  
Larger numbers of significantly enriched GO terms were found in contrasts with a higher 
number of genes with differential expression.  Three GO terms related to response (response 
to stimulus, response to stress and defense response) were discovered among significantly 
97 
 
 
differentially expressed genes in the contrast of NV-C severe day 1 vs. NV-C severe 5.  
Among the other 3 contrasts described (NV-C severe day 5 vs. NV-C mild day 5, NV-C 
severe day 1 vs. NV-NC control day 1, NV-C severe day 5 vs. NV-NC control day 5), a 
variety of metabolic and biosynthetic processes were common.  Prominent within NV-C 
severe day 5 vs. NV-C mild day 5, were GO terms for signal transduction, immune system 
processes, ion homeostasis and, surprisingly, several GO terms centered on reproduction.  
Within NV-C severe vs. NV-NC control, response terms were prominent on day 1, and ion 
homeostasis and DNA structural terms were prominent on day 5.   
 GO analysis of unique and shared differentially expressed genes for 3 contrasts 
(Figure 2) was carried out; NV-C severe day 5 vs. NV-C mild day 5, NV-C severe day 1 vs. 
NV-NC control day 1, NV-C severe day 5 vs. NV-NC control day 5.  Many of the genes 
shared among contrasts were related to immune response.  These included (a) CD4, tumor 
necrosis factor receptor, and Rab11a shared by all 3 contrasts; (b) ATPase, CD5, interferon 
gamma receptor, and toll-like receptor 15 shared by NV-C severe day 1 vs. NV-NC control 
day 1 and NV-C severe day 5 vs. NV-NC control day 5; (c) ATPase, CD3ε, CD200R1, toll-
like receptor 7 shared by NV-C severe day 5 vs. NV-NC control day 5 and NV-C severe day 
5 vs. NV-NC control day 5.  Avian beta-defensins, CD74 and interleukin-8 were unique to 
NV-C severe vs. NV-NC control on day 1, (e).  Unique to NV-C severe vs. NV-C mild on 
day 5 (f) were genes related to ion transport and energy (ATPases and ATP synthases), 
immune response (CD28, CD79b, interleukin 4 receptor, interleukin 10 receptor beta, toll-
like receptor 21), and reproduction. 
 Only two contrasts, NV-C severe day 5 vs. NV-C mild day 5 and NV-C severe day 1 
vs. NV-NC control day 1, had significantly enriched KEGG pathways detected by DAVID 
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(P value < 0.10, Tables 2 and 3).  Many of the pathways exhibited relatedness to defense 
mechanisms, including lysosome pathway, signaling pathways, apoptosis and NK cell 
mediated toxicity. 
 The majority of pathways had higher expression in the severe group compared to 
either mild or control groups, though some, like the cell adhesion molecules pathway and the 
regulation of actin cytoskeleton, had less expression among severe groups. 
Microarray Validation by Quantitative Real Time PCR 
 Fifteen significant genes from the microarray study were validated through qRT-PCR 
analysis: CD 3ε, CD4, CD5, CD28, TLR 7, TLR15, TLR21, HSP70, P20K, Rab11a, AvBD2, 
AvBD4, AvBD5, AvBD6, and AvBD7.  These genes had significant differential expression 
in microarray analysis (q value < 0.05).  Validation was performed on two contrasts of 
interest, NV-C severe day 5 vs. NV-C mild day 5 for CD 3ε, CD4, CD5, CD28, TLR 7, 
TLR15, TLR21, HSP70, P20K, and Rab11a, and NV-C severe day 1 vs. NV-NC day 1 for 
AvBD2, AvBD4, AvBD5, AvBD6, and AvBD7.  Results show similar trends in direction of 
fold change for 12 of the 15 genes analyzed; TLR7, TLR15, and Rab11a were expressed in 
the opposite direction from the microarray, although the results were non-significant. 
Discussion 
 Gene expression differences associated with challenge, pathology, or vaccination 
status, can provide insight into the molecular genetic architecture of host response.  The 
largest amount of gene expression differences occurred between pathology categories 
classified as mild and severe in the NV-C day 5 group.  Several prominent receptor types and 
clusters of differentiation important to immune response and signaling were differentially 
expressed between the mild and severe groups.  The toll-like receptors (TLR) 7, 15 and 21 all 
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experienced high expression in the severe group compared to the mild group.  Surprisingly, 
two of these TLRs showed fold change in the opposite direction in the qRT-PCR results.  
There are several differences in the technical and statistical approaches between microarray 
and qRT-PCR.  These mixed results, however, do still indicate an importance of the TLR 
family with regards to response to infection and illustrate the need for further interrogation.  
TLRs have shown expression changes due to pathogen challenge in multiple tissues (Abasht 
et al., 2008; Lu et al., 2009; Redmond et al., 2009).  In vitro Salmonella stimulation of 
heterophils from a Salmonella-resistant population of birds revealed higher expression of 
TLR15 than heterophils from a Salmonella susceptible population (Nerren et al., 2009), 
consistent with the results of the current qRT-PCR validation.  Cultured macrophages have 
also shown up-regulation of TLR15 when stimulated with E. coli- or Salmonella- derived 
LPS (Ciraci and Lamont, 2011).  It is surprising that in the current study, TLR4 and TLR5 
were not among those genes differentially expressed, because they are considered to be the 
main TLRs for recognizing features of Gram-negative bacteria such as APEC (Brownlie and 
Allan, 2011).  TLR4 expression differences have been reported in heterophils due to bacterial 
challenge and genetic background (Redmond et al., 2009).  TLR4 and TLR5 had differential 
expression in the cecum, TLR4 in the spleen and TLR5 within males in the spleen of 
Salmonella infected chicks (Abasht er al., 2008).   
 Interleukin receptors 4 and 10, and interferon gamma (IFNγ) receptor 2 all 
experienced high expression in the severe group compared to the mild group.  Changes in 
interleukin (IL) receptor genes have been noted in response to pathogen challenge (Crowley 
et al., 2011), although expression changes in IL4R and IL10R have not been extensively 
studied.  IFNγR2 in macrophages exposed to Salmonella endotoxin in vitro was up-regulated 
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4 hours post stimulation (Ciraci et al., 2010).  Tregs, which control the expression of IL-4 
and IFNγ to prevent autoimmunity, have been shown to fail under high antigen dose in vitro 
(George et al., 2003).  Higher expression of receptors for these pro-inflammatory cytokines 
may allow for greater downstream signaling triggered by IL-4 and IFNγ, promoting the 
severe pathology through autoimmunity.  Cytokines are commonly produced by PBL after 
pathogen challenge and have shown differential expression due to bacterial challenge and 
genetic background in heterophils in vitro (Redmond et al., 2009).  Although several 
receptors were up-regulated, no cytokine genes were significantly differentially expressed.   
 Clusters of differentiation (CD) are cell surface molecules common to leukocytes that 
have roles in the immune response.  Differential expression of CD molecules in response to 
Salmonella and Campylobacter infections has been observed in multiple chicken tissues: 
heterophils (Chiang et al., 2008) and jejunum (Schokker et al., 2010) with Salmonella and 
ceca with Campylobacter (Li et al., 2010).  In the current study, many CD molecules had 
higher expression among the mild versus severe pathology group, including CD3ε, CD4, 
CD5, CD28, CD79b and CD200R1.  CD81 was also differentially expressed, but showed 
higher expression in the severe pathology (susceptible) group.  Previous expression studies 
have reported higher levels of CD4 among heterophils from Salmonella resistant chickens 
compared to susceptible lines (Chiang et al., 2008).  This is particularly noteworthy as this 
difference was noted in non-challenged birds, presenting CD4 expression level as a potential 
pre-challenge assessment of susceptibility.  The current study utilized bacterial challenge to 
assess pathology and found higher levels of CD4 among birds showing mild pathology 
(resistant) than in birds demonstrating severe pathology (susceptible).  Many CD molecules 
are associated with or have higher prevalence of specific PBL types (CD3ε among T-cells 
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(Göbel and Fluri, 1997), CD4 among T-cells (Koskinen et al., 2002), ggCD200R-B1 among 
macrophages (Viertlboeck et al., 2008)), suggestive of differences in PBL population 
composition between mildly and severely affected birds that influence downstream 
pathology.  Higher CD4 expression may be indicative of a higher T-helper population within 
birds with mild pathology.  In humans, CD200R1 acts as a regulator of myeloid cell 
activation and pro-inflammatory response (Mukhopadhyay et al., 2010).  Avian CD200R, 
specifically ggCD200R-B1, has high homology to mammalian CD200R (Viertlboeck et al., 
2008).  Lower expression among the severe pathology group would allow an unchecked pro-
inflammatory response, leading to greater host damage. 
 The Ras superfamily can be divided into five major family groups: Ras, Rab, Rho, 
Ran and Arf.  Within the realm of immune response, Ras genes can cause regulatory changes 
in cell proliferation, differentiation and survival, Rho are Ras homologous proteins with roles 
in the cell cycle, Rab proteins have roles in vesicle formation and transport and Arf also has 
roles in vesicle transport (Wennerberg et al., 2005).  Ten members of the Ras superfamily, 
Ras, Rab, Rho and Arf groups, were differentially expressed between pathology groups on 
day 5, introducing a new family of genes to be explored in greater depth in the role of 
immune response.  Seven had higher expression among the severe group and 3 among the 
mild group.  Ras p21 protein activator 3, Rasa3, which is involved in a signaling pathway for 
B-cells to avoid pro-apoptotic signals (Maréchal et al., 2007), was higher amongst the mild 
group.  Rab11a has been shown to have roles in TLR4 trafficking to phagosome and control 
interferon regulatory factor-3 in human monocytes (Husebye et al., 2010).  The conflicting 
result of the qRT-PCR validation in Rab11a, along with the lack of literature on the Ras 
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family in chickens, illustrates the need for more attention to this gene group in the 
investigation of immune response. 
 Differences between the NV-C severe group and the NV-NC group were observed on 
both days.  The number of differentially expressed genes in this contrast decreased over time 
from 1,097 genes on day 1 to 506 on day 5.  This may be due to the rapid response of PBL to 
infection.  Unique to the day 1 comparison of the NV-C severe and NV-NC group for PBL, 
genes encoding avian beta-defensins (AvBD) and interleukin 8 were up-regulated.  The 
genes for AvBD2, 4, 5, 6, and 7 were all rapidly up-regulated by APEC infection.  The 
antimicrobial properties of beta-defensins have been well described (van Dijk et al., 2008).  
AvBD2, 5, 6, and 7 have been found to be expressed in leukocytes (Chiang et al., 2008; van 
Dijk et al., 2008).  TLR agonists, such as LPS, increase AvBD2 in heterophils (Kannan et al., 
2009).  Additionally, structural variants in AvBD genes have been associated with response 
to Salmonella in chickens (Hasenstein et al., 2006; Hasenstein and Lamont, 2007), indicating 
the feasibility of their use in marker-assisted selection to enhance the anti-bacterial response 
on a population level.  The in vitro response of macrophages to Salmonella endotoxin is 
typified by a significant induction of IL8 at 1, 2, 4, and 8 hours post stimulation (Ciraci et al., 
2010).  The chemotactic ability of IL8 for other peripheral blood mononuclear cells and 
heterophils (Barker et al., 1993) is consistent with a role in early response to infection, as 
seen here, with IL8 only significantly induced in the day 1 response. 
 Differential expression was seen among clusters of differentiation genes and in the 
Rab and Rho family groups on day 1 between the NV-C severe and NV-NC group, similar to 
the differential expression between mild and severe pathologies at day 5.  All differentially 
expressed CD genes were down-regulated following APEC challenge: CD4, CD5, CD74, 
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CD82, CD83 and CD247.  A strain of APEC (APEC17) was previously shown to activate 
caspase 3/7 in macrophages, inducing apoptosis (Bastiani et al., 2005).  APEC O1 in the 
current study may result in APEC-induced PBL death, shifting the PBL population structure 
compared to basal (non-challenged) levels.  CD247, also known as the T-cell receptor (TCR) 
ζ-chain, is well conserved between chickens and mammals (Göbel and Bolliger, 1998), and is 
responsible for aiding in assembly of the TCR complex and receptor signaling.   In vitro 
studies of the human ζ-chain have shown degradation by activated caspases (Gastman et al., 
1999), indicating a possible mechanism by which APEC could reduce the abilities of T-cells 
and of the cell-mediated response, resulting in more severe pathology.  Among the Rab and 
Rho genes that were differently expressed, only RhoB was down-regulated in the severe 
pathology group.  Under stress, RhoB inhibits apoptosis and activates NF-κB in rats (Li, Y. 
et al., 2011), such that decrease of expression in severe pathology would allow greater 
apoptosis and limit NF-κB activation.  Rab11a was again higher in the severe pathology 
group in this contrast, along with Rab18, 32 and 35. 
 Fewer significantly differentially expressed genes limited GO analysis and 
interpretation of the NV-C severe day 5 and NV-NC day 5 group comparison.  Similar to 
other contrasts, three CD groups were significantly differentially expressed.  CD3ε, CD4, and 
CD200R1 showed less expression in the NV-C severe group, suggestive of continued 
reduction in CD4+ leukocytes, such as T-cells, and in regulators of pro-inflammatory 
response.  Expression patterns within prominent GO groupings for ion homeostasis and 
cellular developmental processes were inconsistent, with no clear trend of greater expression 
in one treatment group compared to the other. 
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 Many genes were significantly expressed in more than one contrast (Figure 2), which 
is reinforced by the common patterns seen within the treatment/control heatmap (Figure 3).  
Similarities between NV-C severe and NV-C mild on day 5 and NV-C severe vs. NV-NC 
group on day 1 suggest similarities between mild pathology on day 5 and the control groups.  
This could be the result of a return to homeostasis after a successful defense against APEC.  
The changes between the severe pathology group and the control non-challenged group over 
time appear to be driven by the NV-C severe group, as this was the only group to exhibit 
large changes between day 1 and day 5 (Figure 4).   
 Only two contrasts, NV-C severe day 5 vs. NV-C mild day 5 and NV-C severe day 1 
vs. NV-NC control day 1, had significantly enriched KEGG pathways, as detected by 
DAVID (P value < 0.10, Tables 2 and 3).  Between pathology states on day 5, genes that 
enriched metabolic pathways were more highly expressed in the severe group, potentially 
mobilizing more energy to fight infection.  The effect of severe status compared to the non-
challenged control on day 1 illustrates the importance of signaling pathways during early 
response to infection.  
 The lack of a detectible vaccination effect, given the large impact on total lesion 
scores and the tissue analyzed, is surprising.  Vaccination against Newcastle disease virus 
increases serum antibody titers and can impact T cell populations in the 9 weeks following 
vaccination (Dalgaard et al., 2010).  Significant changes in IFNα and IFNγ mRNA 
expression have been reported in peripheral blood at 1 and 7 days post-vaccination to 
Marek’s disease vaccine in 6-8 week old chickens (Quéré et al., 2005).  These chickens were 
then sampled only 4 hours after challenge to observe differential expression patterns due to 
vaccination and challenge (Quéré et al., 2005).  Several cytokines showed significant 
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expression changes 1 day post-vaccination with complete Freund’s adjuvant (Hangalapura et 
al., 2006).  Time of vaccination, time of challenge and time of tissue sampling all impact the 
observed mRNA expression patterns.  Our sampling at 15 and 19 days post-vaccination may 
have been too late to observe expression changes in PBL due to vaccination alone, and 
sampling at 1 and 5 days post-infection may have been too late to observe rapid, vaccine-
induced effects in response to infection. 
 Great insights about how particular cell types react to a foreign agent can be gained 
through targeted in vitro experimentation.  The limitation of in vitro experimentation, 
however, is in knowing how well the information will translate to response at the whole 
organism level.  The in vivo aspect of this experiment is invaluable in its comparison to in 
vitro studies.  By utilizing samples taken from whole blood, the current study detected 
expression differences that are caused by changes in circulating populations, instead of 
focusing on effects in an isolated cell type(s) in culture.  Understanding the systemic nature 
of APEC infections requires study of a whole organism response, which is better measured 
through an in vivo experiment.  It is, however, through targeted in vitro experiments we are 
able to discern between cause and effect of expression, through technologies such as RNAi 
and gene knockdown. 
 Peripheral blood leukocytes are comprised of cells with roles in innate/adaptive 
response and cell/humoral-mediated responses.  Transcriptome interrogation of this system 
reveals which gene expression patterns play an important role in immune response.  
Additionally, these cells can be collected from live birds without the need to harvest the 
breeding animal to assay the cellular response.  Through this greater understanding of host 
response, candidate genes to improve genetic resistance to APEC infection can be identified.  
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Applying selection for beneficial genotypes in breeding populations will generate enhanced 
host responses against APEC infection. 
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Table 1 - Primers utilized for qRT-PCR validation experiments 
Gene Accession Forward Sequence 5’ - 3’ Reverse Sequence 5’ - 3’ 
CD3ε Y08917 CTGCTGTGTGTGGTTGGTG CGGATCTGGCTTCCATTTTA 
CD4 AY528652 ATACCGTGGAGGAAGCTCAT TGCCACCTCATACCAGTGAT 
CD5 Y12011 ACAGGAGGCTGATGAAGAGG CTCTGCTGCTCCTCCACTCT 
CD28 X67915 CAGTCTTTATAATCTACCGGCAAAA TTGTTCTTCTGGTGAGGTGGA 
TLR7 AJ720504 CGGAAAATGGTACATCATGC AAAGTTTTGGGAAACCAACG 
Rab11a AJ720402 GCAAAAGCACCATTGGAGTA GCACCTCGATAGTACGCTGA 
P20K M25784 CTAGGGAGCGGAACTACACG GTTTGGGAAGCAGCATTCAT 
HSP70 NM_001006685 ATAGGGTGGGAGCCAAGAAC   GGTTTCGGTCAAGCCAACT   
AvBD2 AF033336 TTTCTCCAGGGTTGTCTTCG AGCAGCTTCCGACTTTGATT 
AvBD4 AY621306 TTTCATCGTGCTCCTCTTTG   CATAGCCCCAGGTAAGCATT   
AvBD5 AY621307 CCACAAGTCATGTCCTCCAG   CATGGAGATGAACGTGAAGG   
AvBD6 AY621308 TGCAGGTCAGCCCTACTTTT GTCCACTGCCACATGATCC 
AvBD7 AY621309 CTGCTTTCCAGGGATCTGTC GCCAGAGAAGCCATTTGGTA 
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Table 2 - Effect of severity of pathology at day 5 in non-vaccinated, APEC challenged birds 
on KEGG pathway enrichment (P value < 0.10)  
KEGG Pathway Gene Count Accessions 
Lysosome 
gga04142 15 
AJ721124, X95502, AJ851595, 
AJ719840, AJ719682, AJ289021, 
X07775, AJ719710, BX931548, 
AJ720066, AJ720880, AJ721067, 
AJ719318, AJ720351, AJ720226 
Oxidative phosphorylation 
gga00190 12 
BX933021, BX932247, AJ721124, 
AJ720085, AF461018, AJ720322, 
CR382422, CR385488, BX950606, 
AJ719669, AJ289021, BX934066 
Galactose metabolism 
gga00052 5 
AJ719970, AJ721042, AJ719347, 
AF538281, AF534111, AJ719710 
Amino sugar and nucleotide 
sugar metabolism 
gga00520 
7 
AJ719970, AJ719291, AJ721042, 
AJ719347, AB071038, AF538281, 
AJ720584, AF534111 
Cell adhesion molecules (CAMs) 
gga04514 8 
CR390246, M14049, X56559, 
X67915, AY159125, Y08823, 
BX950651, AY528652, X71786 
Calcium signaling pathway 
gga04020 10 
BX930007, Y12601, AF020315, 
AY393849, AF205066, AJ720104, 
AJ012579, AJ719540, M66385, 
NM_001031553 
Pentose phosphate pathway 
gga00030 5 
AJ719291, AJ721042, AF538281, 
AJ720644, AJ720046 
Regulation of actin cytoskeleton 
gga04810 15 
AJ719895, X56559, NM_001031553, 
BX933901, X06387, AJ720675, 
AY046915, BX933838, M24637, 
M14049, AY159125, AJ720866, 
AY460177, X71786, CR523532, 
AJ851398 
Starch and sucrose metabolism 
gga00500 5 
AJ719970, AJ719291, AJ720880, 
AJ721042, AF538281, AF534111 
Nicotinate and nicotinamide 
metabolism 
gga00760 
4 BX930007, AJ851590, CR386613, DQ150102 
Jak-STAT signaling pathway 
gga04630 11 
CR407301, BX933215, X68073, 
AJ719433, AJ720866, AY957508, 
AF082666, AF034576, AJ851398, 
U40844, AF177875 
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Table 3 - Effect of severe pathology at day 1 compared to non-vaccinated, non-challenged 
birds on KEGG pathway enrichment (P value < 0.10) 
KEGG Pathway Gene Count Accessions 
MAPK signaling pathway 
gga04010 12 
AJ851529, AY033635, CR387146, 
AJ720776, AJ851546, X68073, 
BX933236, AJ719540, AF296875, 
AF167296, U10329, AJ851639 
VEGF signaling pathway 
gga04370 6 
AJ851529, AY033635, AJ720776, 
AJ719540, M64990, U10329 
Natural killer cell mediated 
cytotoxicity 
gga04650 
7 
AJ851529, AY033635, AJ720191, 
AJ719540, AF296875, AY957508, 
AJ002317 
NOD-like receptor signaling 
pathway 
gga04621 
5 AY033635, AJ720776, BX935364, AY057939, M16199 
Apoptosis 
gga04210 6 
AJ720191, BX931997, U26645, 
AJ719540, AF296875, AY057939 
Arachidonic acid metabolism 
gga00590 3 AJ006405, M64990, U10329 
DNA replication 
gga03030 4 
AJ720172, AJ719992, AJ719763, 
AJ719578 
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Figure 1 - Treatment Groups 
Chicks were divided into treatment groups at 2 weeks of age by vaccination status, at 4 
weeks of age by challenge status, by day of necropsy post challenge, and by lesion scores 
assigned at necropsy.  Treatment groups are bolded. 
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Figure 2 - Shared Significant Genes 
Comparison of shared significant genes within the 3 contrasts of NV-C Mild day 5 vs. NV-C 
Severe day 5, NV-C Severe day 1 vs. NV-NC group day 1, and NV-C Severe day 5 vs. NV-
NC group day 5.  a) represents shared genes over all 3 contrasts, b-d) represent shared genes 
between 2 contrasts, and e-g) represent genes unique to a contrast.  The numbers in 
parenthesis represent the total number of significant genes within each contrast. 
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Figure 3 - Treatments Compared to Controls 
Heatmap comparison of fold change for each treatment group compared to the day 
appropriate NV-NC control.  Fold change was calculated as log2 (treatment) - log2 (control). 
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Figure 4 - Day 5 Compared to Day 1 
Heatmap comparison of fold change for each day 5 treatment group compared the day 1 
treatment group.  Fold change was calculated as log2 (day 5) - log2 (day 1). 
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Summary  
 Avian pathogenic Escherichia coli (APEC) is a concern for poultry producers and 
exhibits zoonotic potential.  Understanding host transcriptional responses to infection aids 
understanding of protective mechanisms and serves to inform future colibacillosis-control 
strategies.  Transcriptomic results of the splenic and peripheral blood leukocytes (PBL) 
responses to APEC infection in the same individual birds were compared in order to identify 
common patterns and connecting pathways.  Over 100 genes in three contrasts examining 
pathology and infection status were significantly differentially expressed in both tissues and 
similarly regulated.  Differences in catalytic activity appear between mild and severe 
pathology responses.  Early expression differences in the MAPK pathway in PBL precede 
spleen responses in the p53 and cytokine-cytokine receptor pathways.  This type of bi-
analysis is useful in identifying genes and pathways important to the response to APEC, 
whose significance might otherwise go unappreciated. 
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Abbreviations: APEC = avian pathogenic Escherichia coli; Ct = cycle threshold; DPI = day 
post-infection; IRG1 = immunoresponsive homolog 1; MAPK = mitogen activated protein 
kinase; PBL = peripheral blood leukocyte; PCR = polymerase chain reaction 
 
Introduction 
 Avian pathogenic Escherichia coli (APEC) is the causative agent of colibacillosis and 
has zoonotic potential, making it a concern for producers and consumers alike.  APEC 
infection results in extra-intestinal infections, causing decreased body weight, condemnations 
of carcasses and potential animal death (Barnes et al., 2008).  Recent studies show marked 
structural similarities between APEC and human extra-intestinal pathogenic E. coli (ExPEC) 
strains, suggesting that APEC has zoonotic potential and may be a source of virulence genes 
for human ExPEC (Johnson et al., 2007; Johnson et al., 2008; Johnson et al., 2009).   These 
genomic similarities appear to translate to functional similarities, as certain APEC strains are 
able to cause disease in a rat model of human neonatal meningitis (Tivendale et al., 2010). 
 Microarray technology has enabled great advances in our understanding of gene 
function in both microbial pathogens and their hosts.  Small tissue- or pathway-specific 
platforms allow for more targeted research, while use of large global arrays, such as the 
chicken 44K Agilent microarray (Li et al., 2008), can yield more comprehensive data.  
Indeed, the larger arrays are more likely to reveal novel genes or pathways since their probes 
are not restricted to a few elements, often of known function and selected for a particular 
purpose.  Most microarray studies analyze the expression patterns of a particular tissue after 
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disease exposure, but few combine information from multiple tissues to understand on how 
tissues interact to fight infection.  Meta-analyses combine the information gathered from 
multiple studies addressing similar questions, but often the data from such studies originate 
from different individuals or use mRNA that was collected under different experimental 
conditions (Biswas et al., 2011; Daves et al., 2011; Genini et al., 2011).  In the current study, 
transcriptome patterns in spleen and peripheral blood leukocytes (PBL) from the same 
individual chickens were compared in a bi-analysis to better understand the host response to 
APEC.  Better understanding of concurrent function and interaction of tissues can provide 
insight into host response mechanisms and elucidate the best methods to combat disease.  
Analysis of tissues from the same individuals is expected to yield a more refined assessment 
of gene action. 
Materials and Methods 
 Previously published microarray experiments examined two separate tissues; spleen 
(Sandford et al., 2011a) and PBL (Sandford et al., 2011b).  Microarray data are available in 
GEO; Series 25511 and Series 31387 respectively.  Tissues were collected from the same 
experimental study, using the same individual chickens.  Commercial male broiler chickens 
were vaccinated or non-vaccinated at 2 weeks of age, then challenged or non-challenged at 4 
weeks of age with APEC O1 delivered via intra-air sac injection.  Tissues were then 
harvested at 1 and 5 days post-infection (DPI).  Within the non-vaccinated, challenged 
chickens, pathology status was assigned by internal lesion scores.  Three contrasts from these 
two experiments were selected for meta-analysis based on large numbers of significantly 
differentially expressed genes in both tissues: severe pathology vs. mild pathology at 5 DPI, 
severe pathology vs. control at 1 DPI and severe pathology vs. control at 5 DPI (Table 1).  
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Significance for the number of significantly expressed genes in both tissues was established 
through a Chi square test based on 2x2 contingency table.  Pathway analysis was conducted 
using the Database for Annotation, Visualization and Integrated Discovery (DAVID) (Huang 
et al., 2009a; Huang et al., 2009b). 
Results 
Transcriptome meta-analysis 
 In each of the three contrasts examined, a large number of genes were significantly 
differentially expressed in both tissues: 168 genes in severe pathology vs. mild pathology at 5 
DPI, 163 genes severe pathology vs. control at 1 DPI and 114 genes severe pathology vs. 
control at 5 DPI (Fig. 1).  In each instance, the number of genes observed was significantly 
higher than the number expected (P value < 0.0001).  There was a high level of concordance, 
agreement in direction, of expression patterns (>90%) for genes that were significantly 
expressed in both tissues (Fig. 2).  Amongst these gene sets, severe pathology was associated 
with more induction than repression of gene expression (>70%) (Fig. 3).   
 A large number of significantly differentially expressed genes were discovered in 
both tissues at 1 versus 5 days post-infection (Fig. 4).  More genes, 174, were found in 
common between severe pathology and control birds at 1 DPI in PBL (34%) and between 
severe pathology and control at 5 DPI in the spleen (16%), than between severe pathology 
and control at 5 DPI in PBL (6%) and between severe pathology and control at 1 DPI in the 
spleen (4%), 66 genes. 
DAVID 
 Molecular function and biological processes of genes significant to both tissues were 
examined using DAVID (Tables 2-4).  Analysis of significantly differentially expressed 
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genes in severe pathology vs. mild pathology contrast revealed high amounts of genes with 
function in catalytic, lyase and transporter activity (Table 2).  These activities worked 
primarily within metabolic and biosynthetic processes (Table 3).  Greater than 90% of genes 
with catalytic activity had increased expression in the severe pathology compared to the mild 
pathology.  The majority of biological processes associated with severe pathology vs. control 
1 DPI were for response to infection (Table 4), but no molecular functions were found for 
this contrast.  Only one biological process term and one molecular function term were 
significantly enriched among significantly differentially expressed genes between severe 
pathology and control 5 DPI; ‘Generation of precursor metabolites and energy’ was enriched 
with 3 genes and ‘SH3 domain binding’ was enriched with 2 genes.   
 KEGG pathways within each tissue were examined for the contrasts of severe 
pathology compared to control at both 1 and 5 DPI.  Results showed pathway networks 
connecting these two tissues over time.  The MAPK pathway in PBL at 1 DPI experienced a 
12 element enrichment transitioning to downstream pathways in the spleen at 5 DPI, the p53 
and cytokine-cytokine receptor pathways experienced a 6 and 14 element enrichment 
respectively. 
Discussion 
 Examination revealed similarity in gene expression patterns between spleen and PBL.  
Although genes significantly expressed in both tissues were in high concordance, only 6-22% 
of significantly differentially expressed genes from the individual tissue analysis were also 
significantly differentially expressed in the other tissue.  This is surprisingly low, because 
spleen and leukocyte function often work together, with the spleen serving as site of 
leukocyte storage and education (Oláh and Vervelde, 2008).  Results comparing basal 
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expression patterns of 8 different chicken tissues found that the majority of genes assessed 
were expressed in all 8 tissues, 49%, while few were tissue-specific, 14% (Nie et al., 2010).  
The low percentage of significant genes in both tissues in the current study is likely due to 
how each tissue responds to an infection stimulus and not a reflection of if the gene is 
expressed in both tissues.  Expression in response to stimulus illustrates the importance of 
each tissue as an individual site within the whole organism.   
 Comparison of tissues across time points revealed the PBL at 1 DPI shared more 
significant genes with the spleen at 5 DPI than PBL at 5 DPI shared with the spleen at 1 DPI.  
This could be an indication of tissues that respond early or late to infection, or differences in 
the flow of cascading signals.  Time course experiments of other bacterial infections have 
shown increasing rates of colonization over the first 48 hours after infection (Meade et al., 
09).  Many reports of spleen colonization of APEC are measured 48 hours or more after 
infection (Caza et al., 2008; Dheilly et al., 2011; Mellata et al., 2010); whereas, APEC has 
been shown to gain access to the bloodstream hours after intra-air sac inoculation (Stordeur 
et al., 2004; Pourbakhsh et al., 1997).  There has been at least one study showing early 
splenic colonization, but data comparing bacterial counts to those found in blood were not 
reported (Pourbakhsh et al., 1997).  The spleen may not exhibit as strong of an early response 
as the PBL due to differences in time to colonization.   
 KEGG pathway networks were discovered across time points and tissues.  
Enrichment of the MAPK pathway within the PBL at 1 DPI could be responsible for the 
downstream changes in cytokine-cytokine and p53 signaling seen in the spleen at 5 DPI.  
MAPK and p53 pathways are traditionally associated with apoptosis, tumor suppression and 
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viral infection (Lin et al., 2009; Xing et al., 2010).  The increase in genes related to apoptotic 
activity in the severe pathology may contribute to the observed pathology. 
 In both tissues, pathology differences are associated with differences in transport and 
reaction rate.  mRNA expressed from catalytic activity genes were elevated in severe 
pathology group compared to mild pathology group in both tissues.  Increases in catalytic 
activity have previously been associated with greater pathology.  Mouse mutants with an 
inactivated catalytic gene show reduced incidence and severity of lipopolysaccharide induced 
arthritis (Zack et al., 2009).  Few of these catalytic genes have been well studied, especially 
in response to infection, but one gene, IRG1, immunoresponsive 1 homolog, was highly 
expressed the severe pathology groups for both tissues in the current study and has recently 
been associated with infection response.  Expression differences between chickens that are 
resistant and susceptible to Marek’s disease were observed in IRG1 after infection with 
Marek’s virus, with greater expression in the susceptible line (Smith et al., 2011).  Genotypes 
of SNPs found within the promoter region of IRG1 were associated with susceptibility and 
viral counts (Smith et al., 2011).  In the current study, transporter gene levels were elevated 
in the severe pathology, including a copper transporter, solute carrier family 31, member 2.  
Analysis of APEC O1 survival in chicken serum revealed that copper-uptake by APEC is 
necessary for survival and that copper may be of low quantity in serum (Li et al., 2011).  
Thus individuals showing severe pathology may be in competition with APEC for copper 
reserves. 
 Both tissues had increases in expression of antimicrobial genes in the severe 
pathology group compared to the control at 1 DPI.  Several avian beta-defensins were 
significantly increased in both tissues after APEC infection.  The beta-defensins are a well-
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documented antimicrobial gene family with protective responses against bacterial infection 
and their significance was reported on in the original separate tissue specific studies 
(Sandford et al., 20111a, Sandford et al., 2011b).  Two other antimicrobial genes, 
cathelicidin-2 and cathelicidin-3, were significantly increased in both tissues after APEC 
infection.  Cathelicidin-2 has bacterial killing ability (van Dijk et al., 2009a) and is released 
by heterophils after exposure to LPS (van Dijk et al., 2009b).  Consistent with the current 
study’s reports of spleen and PBL, cathelicidin expression increases after infection with 
Salmonella in cecal tonsils (Akbari et al., 2008). 
 Few DAVID terms were discovered for genes significantly differentially expressed 
between severe pathology and control at 5 DPI in both tissues.  This may indicate that later 
responses to infection are more tissue specific. 
 A disadvantage of large scale microarray studies is interpreting the meaning of 
potentially thousands of significant gene expression signals.  Combining information from 
multiple studies or tissues allows refining of the data set and reveal gene sets that may have 
been previously unidentified.  This bi-analysis utilized samples from not only the same 
experiment, but from the same individual birds, giving a strong connection between tissues to 
allow for whole organism examination of transcriptional patterns.  This study provides better 
understanding of the relationship of spleen and PBL in host response to APEC infection. 
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Table 1 - Number of significantly differentially expressed genes in each contrast of interest 
for each tissue 
Contrast of Interest Spleen PBL 
Severe Pathology vs. 
Mild Pathology at 5 DPI 
799 1914 
Severe Pathology vs. 
Control at 1 DPI 
1101 1097 
Severe Pathology vs. 
Control at 5 DPI 
1723 506 
 
 
Table 2 - Enriched molecular function terms between severe pathology and mild pathology 
at 5 DPI in both tissues (P value < 0.05) 
Term Count Genes 
hydro-lyase activity 
GO:0016836 
3 IRG1, ENO2, ACO1 
inorganic cation transmembrane 
transporter activity 
GO:0022890 
4 ATP6V0D2, ATP6V1E1, SLC31A2, TCIRG1 
hydrogen ion transmembrane 
transporter activity 
GO:0015078 
3 ATP6V0D2, ATP6V1E1, TCIRG1 
hydrolase activity, acting on 
glycosyl bonds 
GO:0016798 
3 BST1, GUSB, CHIA 
iron ion binding 
GO:0005506 
4 CYP8B, HBG1, ACO1, HEBP1 
catalytic activity 
GO:0003824 
21 BST1, PNAT3, ABHD12, CAMK2D, 
DALRD3, GALM, ENO2, DIO2, CYP8B, 
CHIA, TCIRG1, ACO1, USP18, RNASET2, 
IRG1, ATP6V1E1, GUSB, NUS1, AKR7A2, 
GSTA3, GCH1 
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Table 3 - Enriched biological process terms between severe pathology and mild pathology at 
5 DPI in both tissues (P value < 0.05) 
Term Count Genes 
generation of precursor 
metabolites and energy 
GO:0006091 
5 ATP6V0D2, ATP6V1E1, ENO2, TCIRG1, 
ACO1 
purine ribonucleoside 
triphosphate metabolic process 
GO:0009205 
4 ATP6V0D2, ATP6V1E1, GCH1, TCIRG1 
ATP synthesis coupled proton 
transport 
GO:0015986 
3 ATP6V0D2, ATP6V1E1, TCIRG1 
purine nucleotide metabolic 
process 
GO:0006163 
4 ATP6V0D2, ATP6V1E1, GCH1, TCIRG1 
catabolic process 
GO:0009056 
6 IRG1, ENO2, GCH1, CHIA, ACO1, USP18 
oxidative phosphorylation 
GO:0006119 
3 ATP6V0D2, ATP6V1E1, TCIRG1 
alcohol metabolic process 
GO:0006066 
4 VLDLR, ENO2, GALM, GCH1 
metabolic process 
GO:0008152 
21 BST1, PNAT3, ATP6V0D2, CAMK2D, 
DALRD3, GALM, ENO2, DIO2, CHIA, 
FOXP1, TCIRG1, ACO1, USP18, IRG1, 
VLDLR, ATP6V1E1, GUSB, AKR7A2, 
NFIL3, GSTA3, GCH1 
amine metabolic process 
GO:0009308 
4 DALRD3, DIO2, GCH1, CHIA 
ATP biosynthetic process 
GO:0006754 
3 ATP6V0D2, ATP6V1E1, TCIRG1 
nucleoside phosphate metabolic 
process 
GO:0006753 
4 ATP6V0D2, ATP6V1E1, GCH1, TCIRG1 
ATP metabolic process 
GO:0046034 
3 ATP6V0D2, ATP6V1E1, TCIRG1 
nucleobase, nucleoside and 
nucleotide metabolic process 
GO:0055086 
4 ATP6V0D2, ATP6V1E1, GCH1, TCIRG1 
purine ribonucleoside 
triphosphate biosynthetic process 
GO:0009206 
3 ATP6V0D2, ATP6V1E1, TCIRG1 
heterocycle metabolic process 
GO:0046483 
4 ATP6V0D2, ATP6V1E1, GCH1, TCIRG1 
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Table 3 (continued) 
Term Count Genes 
nucleoside triphosphate 
biosynthetic process 
GO:0009142 
3 ATP6V0D2, ATP6V1E1, TCIRG1 
 
 
Table 4 - Enriched biological process terms between severe pathology and control at 1 DPI 
in both tissues (P value < 0.05) 
Term Count Genes 
defense response to bacterium 
GO:0042742 
8 GAL7, GAL6, GAL5, CATHL3, GAL4, 
LYG2, CATHL2, GAL2 
defense response 
GO:0006952 
9 GAL7, GAL6, GAL5, CATHL3, GAL4, 
LYG2, CATHL2, TLR15, GAL2 
response to other organism 
GO:0051707 
8 GAL7, GAL6, GAL5, CATHL3, GAL4, 
LYG2, CATHL2, GAL2 
response to stress 
GO:0006950 
12 F13A1, LYG2, CATHL2, PTGS2, MMP2, 
TLR15, GAL7, GAL6, GAL5, GAL4, 
CATHL3, GAL2 
response to stimulus 
GO:0050896 
14 F13A1, LYG2, CATHL2, PTGS2, MMP2, 
TLR15, GAL7, GAL6, GAL5, GAL4, 
CATHL3, BCL2L1, GAL2, AGRP 
innate immune response 
GO:0045087 
3 CATHL3, CATHL2, TLR15 
prostaglandin biosynthetic 
process 
GO:0001516 
2 HPGDS, PTGS2 
growth 
GO:0040007 
3 BCL2L1, PTGS2, LEFTY2 
icosanoid biosynthetic process 
GO:0046456 
2 HPGDS, PTGS2 
140 
 
 
 
Figure 1 - The number of genes significantly expressed in both spleen and PBL tissue in the 
contrasts of (A) severe pathology vs. mild pathology at 5 DPI, (B) severe pathology vs. 
control at 1 DPI, and (C) severe pathology vs. control at 5 DPI. 
 
 
 
Figure 2 - The number of concordantly and discordantly significantly differentially 
expressed genes in each contrast across both tissues.  Many more significant genes were 
concordantly expressed in both tissues. 
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Figure 3 - Regulation of expressed in concordantly expressed genes.  Gene expression was 
primarily increased among concordantly expressed genes. 
 
 
 
Figure 4 - The number of genes significantly expressed between severe pathology and 
control at different days post-infection in spleen and PBL. (A) spleen at 1 DPI compared with 
PBL at 5 DPI, (B) spleen at 5 DPI compared with PBL at 1 DPI 
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CHAPTER 5. GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
Expanding knowledge of host response with large scale, robust animal experiments 
 One difficulty in studying response to disease in animals is the ability to use an 
effective experimental design.  Often, few contrasts or few replicates are examined due to the 
economic and logistic constraints of the experiment.  Here we conducted one of the largest 
disease studies available in the chicken, utilizing approximately 720 individuals, collecting 
thousands of tissues, including spleen, blood, thymus, bursa of Fabricius, bone marrow, liver, 
brain, and air sacs.  With this large size, 10 different experimental groups could be 
represented.  The number of challenged animals included in this study gave us the ability to 
see a large spread in pathological response, thereby allowing maximum separation between 
individuals to characterize mild and severe phenotypes.  The number of disease 
measurements and tissues collected will be valuable resources for future scientists to analyze 
to enhance knowledge about both host and pathogen. 
Infection with avian pathogenic Escherichia coli has a major impact on transcriptomic 
responses 
 The spleen and PBL of chickens infected with APEC exhibited significant changes in 
transcriptomic responses (Chapters 2 and 3).  These changes were reflected in the effects of 
challenge status, day and pathology.  Within the spleen, challenge at any level, regardless of 
pathology or vaccination, produced differential expression from the naïve control birds.  The 
severe pathology group had the largest number of genes differentially expressed compared to 
the control group in both tissues.  This is perhaps reflective of the most dynamic contrast in 
pathological phenotype: non-infected, average basal state, versus susceptible plus infected.  
Overall, greater pathology resulted in more induction of gene expression than repression of 
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gene expression.  This pattern of more abundant induction response has also been recorded in 
the spleens of chickens infected with Salmonella enterica (Zhou and Lamont, 2007), but is 
contrary to results in the spleens of chickens infected with Campylobacter jejuni (Li et al., 
2011).  This may be reflective of the greater amount of phylogenetic similarity between E. 
coli and Salmonella, and potential similar actions within the host, indicating that Salmonella 
is a better comparative infection model for APEC, than Camplyobacter.   
 Choice of time post-challenge is important in understanding APEC infection; status 
of lesions can be milder if measured too early or late in the course of infection (Dwars et al., 
2009).  Time post-challenge played an important role in the identification of differentially 
expressed genes in the current study.  For both tissues, pathology differences were not 
evident until 5 days post-challenge (Chapter 2 and 3).  Time also generated differences in 
tissue roles and infection response.  PBL from circulating blood exhibited high expression 
response due to infection early, which then waned to fewer differentially expressed genes 
later in infection (Chapter 3).  The opposite trend was seen in the spleen, with later responses 
exhibiting higher numbers of differentially expressed genes (Chapter 2).  Early and late 
sampling after infection is necessary to learn more about how these responses are being 
regulated.  Sampling at early, day 1, and late, day 5, response times allowed for the potential 
identification of cascading pathways, early signaling in PBL that influenced later signaling in 
the spleen (Chapter 4).  These studies and others have illustrated the importance of choice of 
time point and the advantage of sampling at multiple time points in a gene expression study 
(Ciraci et al., 2010).   
 Several contrasts of interest saw surprisingly little or no change in expression.  
Detectible differences between the mild pathology and the control only existed in the first 
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day post-challenge in the spleen.  This might be a result of low power to detect, if the 
differences between groups were subtle.  Subtle expression changes may be better detected 
with multiple platforms rather than increased sampling numbers, due to efficiency of binding 
of the probes, or by eliminating pre-filtering of the dataset to control noise.  Our choice of a 
two-color array, howevere, is considered more sensitive than one-color microarray platforms 
to small changes (Pedotti et al., 2008).  Given that the initial bacterial dosage was the same 
for all infected individuals and yet these individuals supported no lesions, it is possible that 
response to bacteria was rapid enough that a homeostatic state resumed within 24 hours.  
However, gene expression differences between severe and mild pathology were different 
than those found between severe pathology and control, indicating some level of 
undetectable expression differences between mild pathology and control.  Neither tissue 
experienced detectable expression differences due to a vaccine effect despite its observed 
efficacy in reducing lesion severity.  Time course studies have shown that time post-
vaccination impacts detectable expression profiles (Gimeno and Cortes, 2011), indicating 
that 15 and 19 days post-vaccination may be a difficult time to observe expression 
differences. 
Spleen and peripheral blood leukocytes are important immunological tissues in the 
fight against APEC infection 
 The spleen displayed differential expression in 9 unique contrasts examined (Chapter 
2).  PBL experienced fewer contrasts with differential expression than the spleen, only 4 
(Chapter 3).  The ability of various leukocytes to phagocytize or use other killing methods is 
important to the clearance of APEC infection.  Isolated heterophils and macrophages are 
often assessed in vitro to determine expression patterns in response to bacteria (Bliss et al., 
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2005; Redmond et al., 2009).  PBL analysis allows for assessment of the entire dynamic 
population of circulating leukocytes.  These tissues have not only illustrated important 
independent function, but also joint expression patterns and pathways.  A significantly 
greater than expected number of genes were significantly expressed in both tissues, with high 
levels of concordance (Chapter 4).  Early signaling pathways in PBL appear to trigger 
downstream pathways in the spleen, illustrating the importance of coordination between 
tissues for proper immune signaling. 
 The response of classical immune family genes, TLRs, AvBDs, and cytokines 
between the two tissues was thought-provoking.  Well-characterized Gram-negative 
receptors, TLR2 and TLR4, were increased in the spleen but not in the PBL, whereas more 
recently identified receptors, TLR7, TLR15, and TLR21, were stimulated in PBL (Chapters 2 
and 3).  TLR7 and TLR15 have been differentially regulated in the spleen in response to 
Clostridium perfringens infection (Lu et al., 2009), but TLR21 has not been extensively 
studied in the spleen, so the extent of TLR21 expression in the spleen is unknown.  AvBDs 
were differentially expressed between pathologies in the spleen but only between the severe 
and control group day 1 post-infection in PBL (Chapters 2 and 3).  Spleen expression 
supports previous work showing differential AvBD expression patterns in intestinal epithelial 
cells of Salmonella resistant and susceptible populations (Derache et al., 2009).  Expression 
changes in cytokine genes seemed limited to the spleen (Chapter 2), although several 
cytokine receptor genes were differentially expressed in PBL (Chapter 3).  The spleen may 
be functioning in a regulatory capacity over PBL, releasing signaling molecules while the 
PBL prepare themselves to more readily bind them and transduce signals.  Macrophages and 
heterophils have shown in vitro stimulation of cytokines hours after challenge, indicating that 
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the later time of sampling may have missed induction in PBL, although the overall immune 
process in the whole organism might be postulated to be slower than in vitro exposure of 
isolated cells to bacteria (Bliss et al., 2005; Redmond et al., 2009). 
Pathology differences exist within commercial broiler populations and are associated 
with differing gene expression 
 In both tissues examined, large gene expression differences existed between 
pathology states, similar to the large expression differences seen in populations characterized 
as resistant or susceptible to Salmonella or Camplylobacter (Chiang et al., 2008; Li et al., 
2011).  A higher number of significant genes were found in the PBL (1,914) than the spleen 
(799) (Chapters 2 and 3).  The differences between mild and severe pathology are important 
for deducing what constitutes a resistant or susceptible phenotype.  A difficulty with gene 
expression profiles is deciphering whether the observed expression is in response to the 
bacterial infection and pathology or the cause of the pathology.  Further investigation into the 
functions of these genes seems to imply that it is both.  Increases in catalytic activity in the 
severe pathology appear to be responsible for host inflicted pathology (Chapter 4).  
Antimicrobial peptide genes were more abundant in the mild group in the spleen, enforcing 
that AvBD are important genes in the control of APEC and expression is increased in 
response to infection. 
 Within this population of male commercial broiler chickens, a large spread of 
pathology was recorded (Chapter 2).  Although these pathology differences can have many 
causes, including environment and bacterial load, there is reason to postulate that genetics is 
also a factor, despite concerns over limited genetic variability within commercial stock (Muir 
et al., 2008).  Genotype has been associated with susceptibility to colibacillosis in broiler 
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lines (Ask et al., 2006), although not associated with any particular genes.  The gene 
expression differences found here can serve as a base for targeted genotype association 
studies in broilers in order to find a possible genetic cause for these expression differences. 
Future directions for researching resistance to APEC 
 Gene expression in this research was assessed using the most cost effective and 
comprehensive available technology at the time, a global microarray.  In the past few years, 
RNA-seq technology has been revolutionary in the quantification of RNA transcripts.  
Microarrays rely on specific probe sequences to capture transcript expression levels, but 
RNA-seq sequences the whole transcript, not limiting itself to preselected genes and allowing 
for identification and quantification of splice variants or allele specific expression (Malone 
and Oliver, 2011).  Utilization of this technology will allow for more precise measurements, 
the ability to examine the role of microRNAs, and better measurement of lowly expressed 
sequences.  Although sequenced, much of the chicken genome still remains unannotated with 
unknown function.  To fully utilize the information provided by these large transcriptomic 
studies, further annotation is required (van den Berg et al., 2010). 
 Analysis of SNP genotype information with phenotypic data can be used to identify 
regions of the genome associated with expression levels.  The chicken has available a 60K 
SNP chip (Groenen et al., 2011), with 650K chips in development (Gheyas et al., 2011), 
allowing for good full genome coverage.  Utilization of these SNP data in combination with 
microarray data will help locate markers associated with expression QTL and aid in the 
attempt to identify causal mutations.  These data can also be utilized to search for SNPs 
associated with lesion scores, to locate QTL or genes associated with phenotype. 
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 Discovering the reason behind the observed pathology will allow researchers to learn 
if susceptibility is primarily the result of an overactive host response or an inadequate 
response to infection.  If the genetic basis for pathology differences can be discerned, it will 
be the first step in identifying resistant animals pre-infection rather than post-infection.  
Further work on expression of other immune tissues can help to complete the story of 
cascading responses.  Meta-analysis of multiple tissues has been shown to help identify 
cross-tissue networks to enhance functional knowledge (Greco et al., 2008).  The next logical 
target would be primary lymphoid organs; bursa of Fabricius, thymus and bone marrow.  
Humoral responses and B-cell activity could be better characterized by the bursa of Fabricius 
and bone marrow while T-cell activity could be better understood by profiling the thymus.   
 Work on understanding APEC, as a bacterium, has shown that many similarities and 
differences exist among strains (Johnson et al., 2008; Maturana et al., 2011; Rodriguez-Siek 
et al., 2005).  How these differences in APEC impact host response should be determined to 
avoid APEC strain-specific improvement of the host, rather than increased resistance to all 
APEC.  Understanding differences between strains may help in utilization of the chicken as a 
model organism for different strains of human ExPEC.  Expression responses are valuable 
tools for understanding host response.  Discovering how gene expression changes in infected 
chickens and at different pathological states will aid in the development of resistant chicken 
lines for healthier poultry and people. 
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